Exact Mass: 312.1784088

Exact Mass Matches: 312.1784088

Found 500 metabolites which its exact mass value is equals to given mass value 312.1784088, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Yakuchinone-A

3-Heptanone, 1-(4-hydroxy-3-methoxyphenyl)-7-phenyl-

C20H24O3 (312.1725354)


1-(4-hydroxy-3-methoxyphenyl)-7-phenyl-3-heptanone is a ketone that is heptan-3-one substituted by a 4-hydroxy-3-methoxyphenyl group at position 1 and a phenyl group at position 7. Isolated from in Alpinia oxyphylla, it exhibits antineoplastic and inhibitory activities against COX-1, COX-2 and NO synthase. It has a role as a metabolite, a cyclooxygenase 1 inhibitor, a cyclooxygenase 2 inhibitor, an EC 1.14.13.39 (nitric oxide synthase) inhibitor and an antineoplastic agent. It is a monomethoxybenzene, a member of phenols and a ketone. Yakuchinone-A is a natural product found in Alpinia oxyphylla with data available. Yakuchinone A is a natural product isolated from the fruit of Alpinia oxyphylla, which can induce apoptosis and has anticancer and anti-inflammatory activities[1]. Yakuchinone A is a natural product isolated from the fruit of Alpinia oxyphylla, which can induce apoptosis and has anticancer and anti-inflammatory activities[1].

   

Oseltamivir

Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid

C16H28N2O4 (312.20489680000003)


Oseltamivir is only found in individuals that have used or taken this drug. It is an acetamido cyclohexene that is a structural homolog of sialic acid and inhibits neuraminidase. [PubChem]Oseltamivir is an ethyl ester prodrug requiring ester hydrolysis for conversion to the active form, oseltamivir carboxylate. The proposed mechanism of action of oseltamivir is inhibition of influenza virus neuraminidase with the possibility of alteration of virus particle aggregation and release. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AH - Neuraminidase inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 658 CONFIDENCE standard compound; INTERNAL_ID 2068 D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Levonorgestrel

(1S,2R,10R,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one

C21H28O2 (312.2089188)


A synthetic progestational hormone with actions similar to those of progesterone and about twice as potent as its racemic or (+-)-isomer (norgestrel). It is used for contraception, control of menstrual disorders, and treatment of endometriosis. It is usually supplied in a racemic mixture (Norgestrel, 6533-00-2). Only the levonorgestrel isomer is active. G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AD - Emergency contraceptives G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AC - Progestogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

   

Granisetron

1-Methyl-N-(endo-9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide

C18H24N4O (312.19500139999997)


Granisetron is only found in individuals that have used or taken this drug. It is a serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic and antinauseant for cancer chemotherapy patients. [PubChem]Granisetron is a potent, selective antagonist of 5-HT3 receptors. The antiemetic activity of the drug is brought about through the inhibition of 5-HT3 receptors present both centrally (medullary chemoreceptor zone) and peripherally (GI tract). This inhibition of 5-HT3 receptors in turn inhibits the visceral afferent stimulation of the vomiting center, likely indirectly at the level of the area postrema, as well as through direct inhibition of serotonin activity within the area postrema and the chemoreceptor trigger zone. A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants > A04AA - Serotonin (5ht3) antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Granisetron (BRL 43694) is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy.

   

Praziquantel

2-cyclohexanecarbonyl-1H,2H,3H,4H,6H,7H,11bH-piperazino[2,1-a]isoquinolin-4-one

C19H24N2O2 (312.18376839999996)


Praziquantel is only found in individuals that have used or taken this drug. It is an anthelmintic used in most schistosome and many cestode infestations. [PubChem]Praziquantel works by causing severe spasms and paralysis of the worms muscles. This paralysis is accompanied - and probably caused - by a rapid Ca 2+ influx inside the schistosome. Morphological alterations are another early effect of praziquantel. These morphological alterations are accompanied by an increased exposure of schistosome antigens at the parasite surface. The worms are then either completely destroyed in the intestine or passed in the stool. An interesting quirk of praziquantel is that it is relatively ineffective against juvenile schistosomes. While initially effective, effectiveness against schistosomes decreases until it reaches a minimum at 3-4 weeks. Effectiveness then increases again until it is once again fully effective at 6-7 weeks. Glutathione S-transferase (GST), an essential detoxification enzyme in parasitic helminths, is a major vaccine target and a drug target against schistosomiasis. Schistosome calcium ion channels are currently the only known target of praziquantel. P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02B - Antitrematodals > P02BA - Quinoline derivatives and related substances D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

   

16-Dehydroprogesterone

(1S,2R,10R,11S,15S)-14-acetyl-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-6,13-dien-5-one

C21H28O2 (312.2089188)


16-Dehydroprogesterone, also known as delta.16-progesterone, belongs to the class of organic compounds known as 20-oxosteroids. These are steroid derivatives carrying a C=O group at the 20-position of the steroid skeleton. Thus, 16-dehydroprogesterone is considered to be a steroid lipid molecule. 16-Dehydroprogesterone is a very hydrophobic molecule, practically insoluble in water, and relatively neutral. Prometrium is a brand of micronized progesterone. It is used as a prescription drug in hormone replacement therapy. [HMDB] D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones 16-Dehydroprogesterone is a steroidal progestin.

   

9-Dehydro-Progesterone

(10S,13S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one

C21H28O2 (312.2089188)


   
   

Broussonin C

5-[3-[4-Hydroxy-3-(3-methylbut-2-enyl)phenyl]propyl]benzene-1,3-diol

C20H24O3 (312.1725354)


   

Centrolobine

d-Centrolobine

C20H24O3 (312.1725354)


   

norajmaline

norajmaline

C19H24N2O2 (312.18376839999996)


An organonitrogen heterocyclic compound that is ajmaline which is lacking the methyl substituent attached to the nitrogen of the dihydroindole moiety.

   

Ethisterone

(1S,2R,10R,11S,14R,15S)-14-ethynyl-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one

C21H28O2 (312.2089188)


Ethisterone is a metabolite of danazol. Ethisterone is a progestogen hormone. The first orally active progestin, ethisterone (pregneninolone, 17α-ethynyltestosterone or 19–norandrostane), the 17α-ethynyl analog of testosterone, was synthesized in 1938 by Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, and Arthur Serini at Schering AG in Berlin and marketed in Germany in 1939 as Proluton C and by Schering in the U.S. in 1945 as Pranone. Ethisterone was also marketed in the U.S. (Wikipedia) G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03D - Progestogens > G03DC - Estren derivatives C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone ATC code: G03DC04

   

(±)-2,4,6-Triphenyl-1-hexene

(3,5-diphenylhex-5-en-1-yl)benzene

C24H24 (312.1877904)


Styrene trimer. Present as an impurity in polystyrene food containers and other products - liberated on heating. Styrene trimer. Present as an impurity in polystyrene food containers and other products - liberated on heating

   

FT-0775232

Pregna-4,11-diene-3,20-dione

C21H28O2 (312.2089188)


   

ST 21:4;O2

18-Hydroxypregna-1,4,20-trien-3-one

C21H28O2 (312.2089188)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones 16-Dehydroprogesterone is a steroidal progestin.

   

17-Allylestra-1,3,5(10)-triene-3,17beta-diol

17-Allylestra-1,3,5(10)-triene-3,17beta-diol

C21H28O2 (312.2089188)


   

NCIOpen2_008463

3-Methoxy-19-norpregna-1,3,5(10)-trien-20-one

C21H28O2 (312.2089188)


   

NCIOpen2_009200

3-Methoxy-19-nor-17alpha-pregna-1,3,5(10),20-tetraen-17-ol

C21H28O2 (312.2089188)


   

1,3,5-Triphenylcyclohexane

2(5)-Phenyl-2(1),2(2),2(3),2(4),2(5),2(6)-hexahydro-1(1),2(1):2(3),3(1)-terphenyl

C24H24 (312.1877904)


1,3,5-Triphenylcyclohexane is a packaging migration residue. Present as an impurity in polystyrene food containers and other products; liberated on heating. Packaging migration residue. Present as an impurity in polystyrene food containers and other products; liberated on heating

   

AR-42

N-[4-[(hydroxyamino)carbonyl]phenyl]-αS-(1-methylethyl)-benzeneacetamide

C18H20N2O3 (312.147385)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Dydrogesterone

Dydrogesterone

C21H28O2 (312.2089188)


G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03D - Progestogens > G03DB - Pregnadien derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone CONFIDENCE standard compound; INTERNAL_ID 2827 CONFIDENCE standard compound; INTERNAL_ID 8747

   

1,3-Dipropyl-8-phenylxanthine

1,3-Dipropyl-8-phenylxanthine

C17H20N4O2 (312.158618)


   

Tetrahydrogestrinone

(10S,11S,14S,15S)-14,15-diethyl-14-hydroxytetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1,6,16-trien-5-one

C21H28O2 (312.2089188)


The identification of tetrahydrogestrinone (THG), the first true "designer androgen," as a sports doping agent reflects both an alarmingly sophisticated illicit manufacturing facility and an underground network of androgen abusers in elite sports, as well as the still untapped potential for designer androgens in medicine. Never marketed, THG was apparently developed as a potent androgen that was undetectable by conventional International Olympic Committee-mandated urinary sports doping tests. As a potent androgen and progestin with unspecified contaminants, its distribution for use at high doses without any prior biological or toxicological evaluation poses significant health risks. Yet this diversion of science also highlights the prospect of designer androgens for use in human medicine. Designer androgens also offer the possibility of tissue-specific effects enhancing the beneficial effects of androgens while mitigating the undesirable ones. Further developments require better understanding of the post receptor tissue selectivity of androgens, comparable to the mechanism underlying that of partial estrogen agonists (SERMs). This experience highlights the ongoing need for vigilance to detect novel drug doping strategies in order to maintain fairness and safety in elite sports. This will require the deployment of generic catch-all tests, such as sensitive and specific in vitro androgen bioassays, coupled with the development of mass spectrometry-based tests for specific doping agents. Starting from gestrinone, chemists can synthesize THG in one reaction step. (PMID: 15934041, 15292520) [HMDB] The identification of tetrahydrogestrinone (THG), the first true "designer androgen," as a sports doping agent reflects both an alarmingly sophisticated illicit manufacturing facility and an underground network of androgen abusers in elite sports, as well as the still untapped potential for designer androgens in medicine. Never marketed, THG was apparently developed as a potent androgen that was undetectable by conventional International Olympic Committee-mandated urinary sports doping tests. As a potent androgen and progestin with unspecified contaminants, its distribution for use at high doses without any prior biological or toxicological evaluation poses significant health risks. Yet this diversion of science also highlights the prospect of designer androgens for use in human medicine. Designer androgens also offer the possibility of tissue-specific effects enhancing the beneficial effects of androgens while mitigating the undesirable ones. Further developments require better understanding of the post receptor tissue selectivity of androgens, comparable to the mechanism underlying that of partial estrogen agonists (SERMs). This experience highlights the ongoing need for vigilance to detect novel drug doping strategies in order to maintain fairness and safety in elite sports. This will require the deployment of generic catch-all tests, such as sensitive and specific in vitro androgen bioassays, coupled with the development of mass spectrometry-based tests for specific doping agents. Starting from gestrinone, chemists can synthesize THG in one reaction step. (PMID: 15934041, 15292520). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens

   

Dydrogesterone

(1R,2S,10S,11S,14S,15S)-14-acetyl-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-6,8-dien-5-one

C21H28O2 (312.2089188)


Dydrogesterone is only found in individuals that have used or taken this drug. It is a synthetic progestational hormone with no androgenic or estrogenic properties. Unlike many other progestational compounds, dydrogesterone produces no increase in temperature and does not inhibit ovulation. [PubChem]Dydrogesterone works by regulating the healthy growth and normal shedding of the womb lining by acting on progesterone receptors in the uterus. G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03D - Progestogens > G03DB - Pregnadien derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

   

Phenylalanylphenylalanine

(2S)-2-{[(2S)-2-azaniumyl-3-phenylpropanoyl]amino}-3-phenylpropanoate

C18H20N2O3 (312.147385)


Phenylalanylphenylalanine (Phe-Phe) is a peptide made of two phenylalanine molecules. Phenylalanine is an essential amino acid and the precursor for the amino acid tyrosine. Like tyrosine, it is the precursor of catecholamines in the body (tyramine, dopamine, epinephrine and norepinephrine). The psychotropic drugs (mescaline, morphine, codeine, and papaverine) also have phenylalanine as a constituent. Phenylalanine is a precursor of the neurotransmitters called catecholamines, which are adrenalin-like substances. Phenylalanine is highly concentrated in the human brain and plasma. The Phe-Phe recognition motif of the Alzheimer?s Abeta peptide is the smallest peptide able to assemble into higher ?order structures.(PMC:1796831) [HMDB] Phenylalanylphenylalanine (Phe-Phe) is a peptide made of two phenylalanine molecules. Phenylalanine is an essential amino acid and the precursor for the amino acid tyrosine. Like tyrosine, it is the precursor of catecholamines in the body (tyramine, dopamine, epinephrine and norepinephrine). The psychotropic drugs (mescaline, morphine, codeine, and papaverine) also have phenylalanine as a constituent. Phenylalanine is a precursor of the neurotransmitters called catecholamines, which are adrenalin-like substances. Phenylalanine is highly concentrated in the human brain and plasma. The Phe-Phe recognition motif of Alzheimers amyloid-beta peptide is the smallest peptide able to assemble into higher-order structures (PMID: 17172307).

   

Methyl (9Z)-10'-oxo-6,10'-diapo-6-carotenoate

Methyl (4Z,6E,8E,10E,12E,14E)-4,8,13-trimethyl-16-oxohexadeca-2,4,6,8,10,12,14-heptaenoic acid

C20H24O3 (312.1725354)


Methyl (9Z)-10-oxo-6,10-diapo-6-carotenoate is a constituent of Bixa orellana (annatto) Constituent of Bixa orellana (annatto).

   

5-Methoxy-7-(4-hydroxyphenyl)-1-phenyl-3-heptanone

7-(4-hydroxyphenyl)-5-methoxy-1-phenylheptan-3-one

C20H24O3 (312.1725354)


5-Methoxy-7-(4-hydroxyphenyl)-1-phenyl-3-heptanone is found in herbs and spices. 5-Methoxy-7-(4-hydroxyphenyl)-1-phenyl-3-heptanone is a constituent of Alpinia officinarum (lesser galangal). Constituent of Alpinia officinarum (lesser galangal). 5-Methoxy-7-(4-hydroxyphenyl)-1-phenyl-3-heptanone is found in herbs and spices.

   

Chloropanaxydiol

1-chloro-8-(3-heptyloxiran-2-yl)octa-4,6-diyne-2,3-diol

C17H25ClO3 (312.14921300000003)


Chloropanaxydiol is found in tea. Chloropanaxydiol is isolated from the dried callus of Panax ginseng (ginseng

   

4'-Hydroxy-5,5'-diisopropyl-2,2'-dimethyl-3,4-biphenylquinone

4-[4-hydroxy-2-methyl-5-(propan-2-yl)phenyl]-3-methyl-6-(propan-2-yl)cyclohexa-3,5-diene-1,2-dione

C20H24O3 (312.1725354)


4-Hydroxy-5,5-diisopropyl-2,2-dimethyl-3,4-biphenylquinone is found in herbs and spices. 4-Hydroxy-5,5-diisopropyl-2,2-dimethyl-3,4-biphenylquinone is a constituent of the leaves of thyme (Thymus vulgaris). Shows antioxidant activity. Constituent of the leaves of thyme (Thymus vulgaris). Shows antioxidant activity. 4-Hydroxy-5,5-diisopropyl-2,2-dimethyl-3,4-biphenylquinone is found in herbs and spices.

   

Ethopropazine

N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine

C19H24N2S (312.1660104)


Ethopropazine is only found in individuals that have used or taken this drug.Ethopropazine (also known as profenamine hydrochloride) is a medication derived from phenothiazine. It is primarily used as an antidyskinetic to treat parkinsonism. It is sold under the trade names Parsidol in the United States and Parsidan in Canada.Ethopropazines antiparkinson action can be attributed to its anticholinergic properties. Ethopropazine partially blocks central (striatal) cholinergic receptors, thereby helping to balance cholinergic and dopaminergic activity in the basal ganglia; salivation may be decreased, and smooth muscle may be relaxed. Drug-induced extrapyramidal symptoms and those due to parkinsonism may be relieved, but tardive dyskinesia is not alleviated and may be aggravated by anticholinergic effects. Ethopropazines local anesthetic effect is due to its antagonism of the NMDA glutamate receptor. Glutamate is recognized as an important transmitter in nociceptive pathways, and the N-methyl-D-aspartate (NMDA) subtype of the glutamate receptor, in particular, has been implicated in the mediation of neuropathic pain. Excessive release of glutamate at NMDA receptors on dorsal horn neurons of the spinal cord results in hyperactivation and hypersensitivity of these receptors (perceived as hyperalgesia), thought to be an integral feature of neuropathic pain. N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   

N-Undecylbenzenesulfonic acid

4-Undecylbenzene-1-sulphonic acid

C17H28O3S (312.1759058)


N-Undecylbenzenesulfonic acid is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") It is used as a food additive .

   

1,2,3,4-Tetrahydro-1-phenyl-4-(2-phenylethyl)naphthalene

1-phenyl-4-(2-phenylethyl)-1,2,3,4-tetrahydronaphthalene

C24H24 (312.1877904)


1,2,3,4-Tetrahydro-1-phenyl-4-(2-phenylethyl)naphthalene is a packaging migration residue. Packaging migration residue

   

1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene

1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene

C24H24 (312.1877904)


1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene is a packaging migration residue. Packaging migration residue

   

2-hydroxyethinylestradiol

(17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-2,3,17-triol

C20H24O3 (312.1725354)


2-hydroxyethinylestradiol is a metabolite of ethinyl estradiol. Ethinyl estradiol (EE) /ˌɛθɨnɨlˌiːstrəˈdaɪ.əl/, also sometimes written as ethinylestradiol, ethynyl estradiol, or ethinyl œstradiol, is a derivative of 17β-estradiol (E2), the major endogenous estrogen in humans. EE is an orally bioactive estrogen used in many formulations of combined oral contraceptive pills. It is one of the most commonly used medications for this purpose. (Wikipedia)

   

(+)-Norgestrel

15-ethyl-14-ethynyl-14-hydroxytetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one

C21H28O2 (312.2089188)


D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

   

Arteether

10-ethoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0⁴,¹³.0⁸,¹³]hexadecane

C17H28O5 (312.1936638)


   

Progestoral

14-ethynyl-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one

C21H28O2 (312.2089188)


   

(S)-N-Hydroxy-4-(3-methyl-2-phenylbutanamido)benzamide

N-hydroxy-4-[(3-methyl-2-phenylbutanoyl)amino]benzamide

C18H20N2O3 (312.147385)


   

7alpha-Methyl-17-ethinyl-19-nortestosterone

14-ethynyl-14-hydroxy-9,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one

C21H28O2 (312.2089188)


   

1,1-Bis(P-ethoxyphenyl)-2,2-dimethylpropane

1-ethoxy-4-[1-(4-ethoxyphenyl)-2,2-dimethylpropyl]benzene

C21H28O2 (312.2089188)


   

E-Guggulsterone

14-ethylidene-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-ene-5,13-dione

C21H28O2 (312.2089188)


   

Propamidine

4-[3-(4-carbamimidoylphenoxy)propoxy]benzene-1-carboximidamide

C17H20N4O2 (312.158618)


D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AC - Biguanides and amidines D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives

   

1-Isopropyl-6-methylergoline-8-carboxylic acid

6-methyl-11-(propan-2-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carboxylic acid

C19H24N2O2 (312.18376839999996)


   

tibolone

14-ethynyl-14-hydroxy-9,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-2(7)-en-5-one

C21H28O2 (312.2089188)


   

Xylamidine

N-[2-(3-methoxyphenoxy)propyl]-2-(3-methylphenyl)ethanimidamide

C19H24N2O2 (312.18376839999996)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

Ethyl 4-methyl-5-(1-methylethoxy)-9H-pyrido(3,4-b)indole-3-carboxylate

Ethyl 4-methyl-5-(propan-2-yloxy)-9H-pyrido[3,4-b]indole-3-carboxylic acid

C18H20N2O3 (312.147385)


D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

Norajmaline

13-Ethyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol

C19H24N2O2 (312.1837684)


Norajmaline is a member of the class of compounds known as ajmaline-sarpagine alkaloids. Ajmaline-sarpagine alkaloids are organic compounds containing either of the ajmalan, sarpagan skeleton, or derivative thereof. The Sarpagine (Akuammidine) group, based on the sarpagan nucleus, arises from bond formation between C-16 and C-5 of the corynantheine precursor. Ajmaline alkaloids are based on a 17,19-secoyohimban skeleton (oxayohimban) which is invariably present as an ether. Norajmaline is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Norajmaline can be found in a number of food items such as roselle, chayote, savoy cabbage, and onion-family vegetables, which makes norajmaline a potential biomarker for the consumption of these food products.

   

Hypolide

Phenanthro(1,2-c)furan-1(3H)-one, 3b,4,5,9b,10,11-hexahydro-6-hydroxy-9b-methyl-7-(1-methylethyl)-, (3bR-trans)-

C20H24O3 (312.1725354)


(3bR,9bS)-6-hydroxy-9b-methyl-7-propan-2-yl-3,3b,4,5,10,11-hexahydronaphtho[2,1-e]isobenzofuran-1-one is an oxo steroid. Triptophenolide is a natural product found in Tripterygium regelii, Tripterygium hypoglaucum, and other organisms with data available. Triptophenolide is a colorless crystalline plate isolated from ethyl acetate extracts of Tripterygium wilfordii. IC50 value: Target: In vitro: Triptophenolide can remarkably inhibit the delayed type hypersensitivity (DTH) reaction induced by DNCB and BSA; and diminished the peripheral blood ANAE+lymphocytes in rats and micc. Moreover, triptophenolide can dramatically increase the amount of total serum complement and significautly decrcase the serum antibody products (1gG ) of rats and mice. The phagocytosis of perioneal exudate macrophages in mice present double effects in vitro [1]. In vivo: Triptophenolide is a colorless crystalline plate isolated from ethyl acetate extracts of Tripterygium wilfordii. IC50 value: Target: In vitro: Triptophenolide can remarkably inhibit the delayed type hypersensitivity (DTH) reaction induced by DNCB and BSA; and diminished the peripheral blood ANAE+lymphocytes in rats and micc. Moreover, triptophenolide can dramatically increase the amount of total serum complement and significautly decrcase the serum antibody products (1gG ) of rats and mice. The phagocytosis of perioneal exudate macrophages in mice present double effects in vitro [1]. In vivo:

   

Guggulsterone

(8R,9S,10R,13S,14S,17Z)-17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione

C21H28O2 (312.2089188)


Guggulsterone is a 3-hydroxy steroid. It has a role as an androgen. Guggulsterone is a natural product found in Commiphora mukul and Commiphora wightii with data available. E-Guggulsterone is a 3-hydroxy steroid. It has a role as an androgen. E-Guggulsterone is a natural product found in Commiphora mukul and Commiphora wightii with data available. (-)-(E)-Guggulsterone is the metabolite of Z-guggulsterone. Guggulsterone is an active constituent of guggulipid, an ayurvedic agent derived from Commiphora mukul. Guggulsterone has hypolipidaemic activity[1]. (-)-(E)-Guggulsterone is the metabolite of Z-guggulsterone. Guggulsterone is an active constituent of guggulipid, an ayurvedic agent derived from Commiphora mukul. Guggulsterone has hypolipidaemic activity[1]. (Z)-Guggulsterone, a constituent of Indian Ayurvedic medicinal plant Commiphora mukul, inhibits the growth of human prostate cancer cells by causing apoptosis. (Z)-Guggulsterone inhibits angiogenesis by suppressing the VEGF–VEGF-R2–Akt signaling axis[1]. (Z)-Guggulsterone is also a potent FXR antagonist. (Z)-Guggulsterone reduces ACE2 expression and SARS-CoV-2 infection[2]. (Z)-Guggulsterone, a constituent of Indian Ayurvedic medicinal plant Commiphora mukul, inhibits the growth of human prostate cancer cells by causing apoptosis. (Z)-Guggulsterone inhibits angiogenesis by suppressing the VEGF–VEGF-R2–Akt signaling axis[1]. (Z)-Guggulsterone is also a potent FXR antagonist. (Z)-Guggulsterone reduces ACE2 expression and SARS-CoV-2 infection[2]. Guggulsterone is a plant sterol derived from the gum resin of the tree Commiphora wightii. Guggulsterone inhibits the growth of a wide variety of tumor cells and induces apoptosis through down regulation of antiapoptotic gene products (IAP1, xIAP, Bfl-1/A1, Bcl-2, cFLIP and survivin), modulation of cell cycle proteins (cyclin D1 and c-Myc), activation of caspases and JNK, inhibition of Akt[1]. Guggulsterone, a farnesoid X receptor (FXR) antagonist, decreases CDCA-induced FXR activation with IC50s of 17 and 15 μM for Z- and E-Guggulsterone, respectively[2]. Guggulsterone is a plant sterol derived from the gum resin of the tree Commiphora wightii. Guggulsterone inhibits the growth of a wide variety of tumor cells and induces apoptosis through down regulation of antiapoptotic gene products (IAP1, xIAP, Bfl-1/A1, Bcl-2, cFLIP and survivin), modulation of cell cycle proteins (cyclin D1 and c-Myc), activation of caspases and JNK, inhibition of Akt[1]. Guggulsterone, a farnesoid X receptor (FXR) antagonist, decreases CDCA-induced FXR activation with IC50s of 17 and 15 μM for Z- and E-Guggulsterone, respectively[2]. Guggulsterone is a plant sterol derived from the gum resin of the tree Commiphora wightii. Guggulsterone inhibits the growth of a wide variety of tumor cells and induces apoptosis through down regulation of antiapoptotic gene products (IAP1, xIAP, Bfl-1/A1, Bcl-2, cFLIP and survivin), modulation of cell cycle proteins (cyclin D1 and c-Myc), activation of caspases and JNK, inhibition of Akt[1]. Guggulsterone, a farnesoid X receptor (FXR) antagonist, decreases CDCA-induced FXR activation with IC50s of 17 and 15 μM for Z- and E-Guggulsterone, respectively[2].

   

Thymol glucoside

Thymol-beta-D-glucoside

C16H24O6 (312.1572804)


   

6-hydroxy-9b-methyl-7-propan-2-yl-3,3b,4,5,10,11-hexahydronaphtho[2,1-e][2]benzofuran-1-one

6-hydroxy-9b-methyl-7-propan-2-yl-3,3b,4,5,10,11-hexahydronaphtho[2,1-e][2]benzofuran-1-one

C20H24O3 (312.1725354)


   
   

(+)-Neomethynolide

(+)-Neomethynolide

C17H28O5 (312.1936638)


   
   
   

2-EpicycloisoBrachycoumarin

2-EpicycloisoBrachycoumarin

C20H24O3 (312.1725354)


   
   
   

4-Geranyloxy-5-methyl coumarin

4-Geranyloxy-5-methyl coumarin

C20H24O3 (312.1725354)


   

Hydrocupreine

6-Hydroxydihydrocinchonidine

C19H24N2O2 (312.18376839999996)


   
   

2alpha-Hydroxyjatropholone

(+)-2alpha-Hydroxyjatropholone

C20H24O3 (312.1725354)


   

3-Oxomicrostegiol

3-Oxomicrostegiol

C20H24O3 (312.1725354)


   
   
   

5,6-Didehydro-O-methylsugiol

5,6-Didehydro-O-methylsugiol

C21H28O2 (312.2089188)


   

Stapfinine

5-hydroxyvoaphylline

C19H24N2O2 (312.18376839999996)


   
   
   
   
   

Cyclobrachycoumarin

Cyclobrachycoumarin

C20H24O3 (312.1725354)


   

Rubifolide

(+)-Rubifolide

C20H24O3 (312.1725354)


   
   
   
   

2beta-Hydroxyjatropholone

(+)-2beta-Hydroxyjatropholone

C20H24O3 (312.1725354)


   

2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one

2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one

C17H20N4O2 (312.158618)


   

5-(2-Ethoxyphenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one

5-(2-Ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]-7-pyrimidinone

C17H20N4O2 (312.158618)


   

Ethanediamide, N-(2-ethoxyphenyl)-N-(2-ethylphenyl)-

Ethanediamide, N-(2-ethoxyphenyl)-N-(2-ethylphenyl)-

C18H20N2O3 (312.147385)


   

Tibolone

17α-hydroxy-7α-methyl-19-norpregn-5(10)-en-20-yn-3-one

C21H28O2 (312.2089188)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D020847 - Estrogen Receptor Modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03C - Estrogens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000970 - Antineoplastic Agents

   

4-(undecan-5-yl)benzene-1-sulfonic acid

4-(undecan-5-yl)benzene-1-sulfonic acid

C17H28O3S (312.1759058)


   

THYMOL-B-D-GLUCOPYRANOSIDE

THYMOL-B-D-GLUCOPYRANOSIDE

C16H24O6 (312.1572804)


   

Pyrenophorol

5,13-Dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1572804)


   

tetrahydropyrenophorin

tetrahydropyrenophorin

C16H24O6 (312.1572804)


   
   

17alpha-ethynylestra-1,3,5(10)-trien-3,6alpha,17beta-triol|19-norpregna-1,3,5(10)-triene-20-yne-3,6alpha,17beta-triol|6alpha-hydroxy-ethinylestradiol|6alpha-hydroxy-ethynylestradiol

17alpha-ethynylestra-1,3,5(10)-trien-3,6alpha,17beta-triol|19-norpregna-1,3,5(10)-triene-20-yne-3,6alpha,17beta-triol|6alpha-hydroxy-ethinylestradiol|6alpha-hydroxy-ethynylestradiol

C20H24O3 (312.1725354)


   
   

2-Phenyl-4--6-hydroxymethyl-2,3-dihydro-1,4-benzoxazin-3-on|6-hydroxymethyl-4-(2-methylamino-ethyl)-2-phenyl-4H-benzo[1,4]oxazin-3-one

2-Phenyl-4--6-hydroxymethyl-2,3-dihydro-1,4-benzoxazin-3-on|6-hydroxymethyl-4-(2-methylamino-ethyl)-2-phenyl-4H-benzo[1,4]oxazin-3-one

C18H20N2O3 (312.147385)


   
   
   
   
   
   
   
   
   
   
   

3,4,18beta-cyclopropa-14-oxo-ent-abieta-8,9,13,15-dien-16,12-olide|retusolide B

3,4,18beta-cyclopropa-14-oxo-ent-abieta-8,9,13,15-dien-16,12-olide|retusolide B

C20H24O3 (312.1725354)


   
   
   

18-Hydroxy-pregna-1,4,20-trien-3-on

18-Hydroxy-pregna-1,4,20-trien-3-on

C21H28O2 (312.2089188)


   

17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione

17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione

C21H28O2 (312.2089188)


   

9E-Isomer-Neolaugerine|neolaugerine

9E-Isomer-Neolaugerine|neolaugerine

C19H24N2O2 (312.18376839999996)


   

Peroxyplakoric acid A3

Peroxyplakoric acid A3

C17H28O5 (312.1936638)


   
   

methyl (Z)-4-<(2E,5E)-3,7-dimethylocta-2,5,7-trienyloxy>cinnamate

methyl (Z)-4-<(2E,5E)-3,7-dimethylocta-2,5,7-trienyloxy>cinnamate

C20H24O3 (312.1725354)


   

N(1)-desacetyl 18-hydroxyisoretuline|N-desacetyl-18-hydroxyisoretuline|Na-Desacetyl-18-hydroxyisoretuline

N(1)-desacetyl 18-hydroxyisoretuline|N-desacetyl-18-hydroxyisoretuline|Na-Desacetyl-18-hydroxyisoretuline

C19H24N2O2 (312.18376839999996)


   

15,16-Epoxy-neo-clerodan-1,3,13(16),14-tetraen-18,19-olide

15,16-Epoxy-neo-clerodan-1,3,13(16),14-tetraen-18,19-olide

C20H24O3 (312.1725354)


   

(3S,5R)-3-Hydroxy-5-methoxy-1-(4-hydroxyphenyl)-7-phenyl-6E-heptene

(3S,5R)-3-Hydroxy-5-methoxy-1-(4-hydroxyphenyl)-7-phenyl-6E-heptene

C20H24O3 (312.1725354)


   
   
   

(4bS,8aS)-4b,5,6,7,8,8a-Hexahydro-3-hydroxy-4b,8,8-trimethyl-2-(2-propenyl)phenanthren-1,4-dion|Lanugon A

(4bS,8aS)-4b,5,6,7,8,8a-Hexahydro-3-hydroxy-4b,8,8-trimethyl-2-(2-propenyl)phenanthren-1,4-dion|Lanugon A

C20H24O3 (312.1725354)


   

cleistha-8,11,13-trien-7-one-19,20beta-olide

cleistha-8,11,13-trien-7-one-19,20beta-olide

C20H24O3 (312.1725354)


   

Botrydial, dihydro-

Botrydial, dihydro-

C17H28O5 (312.1936638)


   
   
   

7-oxo-18(4->3)abeo-abieta-3,8,11,13-tetraen-18-oic acid

7-oxo-18(4->3)abeo-abieta-3,8,11,13-tetraen-18-oic acid

C20H24O3 (312.1725354)


   
   

2-(4-hydroxy-phenyl)-6-methyl-4-(2-methylamino-ethyl)-4H-benzo[1,4]oxazin-3-one|2-<4(?)-Hydroxyphenyl>-4--6-methyl-2,3-dihydro-1,4-benzoxazin-3-on

2-(4-hydroxy-phenyl)-6-methyl-4-(2-methylamino-ethyl)-4H-benzo[1,4]oxazin-3-one|2-<4(?)-Hydroxyphenyl>-4--6-methyl-2,3-dihydro-1,4-benzoxazin-3-on

C18H20N2O3 (312.147385)


   

Gravelliferon-methylaether|gravelliferone methyl ether|Me ether-Gravelliferone|Methyl-gravelliferon

Gravelliferon-methylaether|gravelliferone methyl ether|Me ether-Gravelliferone|Methyl-gravelliferon

C20H24O3 (312.1725354)


   
   
   
   

4beta-acetoxy-9beta,10beta,15alpha-trihydroxyprobotrydial

4beta-acetoxy-9beta,10beta,15alpha-trihydroxyprobotrydial

C17H28O5 (312.1936638)


   

(1S*,6R*,7S*,8S*,11R*)-6,11-diphenyltricyclo[6.2.2.02,7]dodeca-2,9-diene

(1S*,6R*,7S*,8S*,11R*)-6,11-diphenyltricyclo[6.2.2.02,7]dodeca-2,9-diene

C24H24 (312.1877904)


   

(-)-neoavarone|2-[[(1R,2S,4aS,8aS)-1,2,4a-trimethyl-5-(methylene)decahydronaphthalen-1-yl]methyl]cyclohexa-2,5-diene-1,4-dione|isoavarone|neoavarone

(-)-neoavarone|2-[[(1R,2S,4aS,8aS)-1,2,4a-trimethyl-5-(methylene)decahydronaphthalen-1-yl]methyl]cyclohexa-2,5-diene-1,4-dione|isoavarone|neoavarone

C21H28O2 (312.2089188)


   

17alpha-ethynyl-1,4-estradien-10,17beta-diol-3-one|17alpha-Ethynyl-1,4-estradiene-10,17beta-diol-3-one

17alpha-ethynyl-1,4-estradien-10,17beta-diol-3-one|17alpha-Ethynyl-1,4-estradiene-10,17beta-diol-3-one

C20H24O3 (312.1725354)


   
   

(3aS,5aR,12bS,12cR)-2,3,3a,4,5a,6,11,12,12b,12c-decahydro-3a,12b-dimethylfuro[3,2:5,6]cyclohepta[1,2:3,4]naphtho[1,8-bc]furan-9(1H)-one|limbatenolide B

(3aS,5aR,12bS,12cR)-2,3,3a,4,5a,6,11,12,12b,12c-decahydro-3a,12b-dimethylfuro[3,2:5,6]cyclohepta[1,2:3,4]naphtho[1,8-bc]furan-9(1H)-one|limbatenolide B

C20H24O3 (312.1725354)


   
   
   

2-Methylpropanoyl-(2E,9Z)-2,9,16-Heptadecatriene-4,6-diyn-1-ol

2-Methylpropanoyl-(2E,9Z)-2,9,16-Heptadecatriene-4,6-diyn-1-ol

C21H28O2 (312.2089188)


   

Me ether-Ostruthin

Me ether-Ostruthin

C20H24O3 (312.1725354)


   
   
   
   

4-Methyl-2-(2,3-dimethylbenzyl)-3-[[(3-methyl-2-butenoyl)oxy]methyl]furan

4-Methyl-2-(2,3-dimethylbenzyl)-3-[[(3-methyl-2-butenoyl)oxy]methyl]furan

C20H24O3 (312.1725354)


   

7-Hydroxyhedychenone

7-Hydroxyhedychenone

C21H28O2 (312.2089188)


   

11,12E-dehydrostrictic acid

11,12E-dehydrostrictic acid

C20H24O3 (312.1725354)


   
   

1,2,11,12E-tetradehydrohardwickiic acid

1,2,11,12E-tetradehydrohardwickiic acid

C20H24O3 (312.1725354)


   
   

(3S,6S)-3-acetoxy-2,2,6-trimethyl-6-([1S,4R]-4-hydroperoxy-4-methylcyclohex-2-en-1-yl)tetrahydropyran

(3S,6S)-3-acetoxy-2,2,6-trimethyl-6-([1S,4R]-4-hydroperoxy-4-methylcyclohex-2-en-1-yl)tetrahydropyran

C17H28O5 (312.1936638)


   
   

17-Hydroxy-16-decarbomethoxydihydroepiajmalicine

17-Hydroxy-16-decarbomethoxydihydroepiajmalicine

C19H24N2O2 (312.18376839999996)


   
   
   

E-1-[2,4-dihydroxy-5-(3-hydroxy-3-methylbutyl)benzyl]-2-phenylethylene|erythbidin C

E-1-[2,4-dihydroxy-5-(3-hydroxy-3-methylbutyl)benzyl]-2-phenylethylene|erythbidin C

C20H24O3 (312.1725354)


   

11-hydroxy-5,7,9,13-abietatetraene-2,12-dione

11-hydroxy-5,7,9,13-abietatetraene-2,12-dione

C20H24O3 (312.1725354)


   

3-oxoandrost-4,6,15-trien-16-oic acid

3-oxoandrost-4,6,15-trien-16-oic acid

C20H24O3 (312.1725354)


   

Cneorum-Chromon-H

Cneorum-Chromon-H

C20H24O3 (312.1725354)


   
   
   

2-methyl-5-(1-methylethyl)phenyl beta-D-glucopyranoside|2-methyl-5-(1-methylethyl)phenyl-beta-D-glucopyranoside|carvacryl beta-D-glucopyranoside

2-methyl-5-(1-methylethyl)phenyl beta-D-glucopyranoside|2-methyl-5-(1-methylethyl)phenyl-beta-D-glucopyranoside|carvacryl beta-D-glucopyranoside

C16H24O6 (312.1572804)


   
   

3-Ethyl-3-hydroxy-1,3-ethano-1,3-propanospiro[1H-indole-2(3H),2-piperidine]-9-one

3-Ethyl-3-hydroxy-1,3-ethano-1,3-propanospiro[1H-indole-2(3H),2-piperidine]-9-one

C19H24N2O2 (312.18376839999996)


   
   
   
   
   

15beta-hydroxypregna-1,4,20-trien-3-one

15beta-hydroxypregna-1,4,20-trien-3-one

C21H28O2 (312.2089188)


   

4-epi-curcusone E

4-epi-curcusone E

C20H24O3 (312.1725354)


   

montbretyl 12-methyl ether

montbretyl 12-methyl ether

C21H28O2 (312.2089188)


   

(?)-(5S,10S)-13-isopropyl-7-oxo-abieta-8,11,13-trien-20-oicacid|inonotusic acid

(?)-(5S,10S)-13-isopropyl-7-oxo-abieta-8,11,13-trien-20-oicacid|inonotusic acid

C21H28O2 (312.2089188)


   
   
   
   

12-Hydroxysapriparaquinone

12-Hydroxysapriparaquinone

C20H24O3 (312.1725354)


   

2,3,4-trimethylbenzyl alcohol-O-beta-D-glucopyranoside|2,3,4-trimethylbenzylalcohol-O-beta-D-glucopyranoside

2,3,4-trimethylbenzyl alcohol-O-beta-D-glucopyranoside|2,3,4-trimethylbenzylalcohol-O-beta-D-glucopyranoside

C16H24O6 (312.1572804)


   

Pygmaeocin C|Pygmaoecin C

Pygmaeocin C|Pygmaoecin C

C20H24O3 (312.1725354)


   

2-Hydroxysaprorthoquinone

2-Hydroxysaprorthoquinone

C20H24O3 (312.1725354)


   

1-acetate of lapiferol

1-acetate of lapiferol

C17H28O5 (312.1936638)


   
   

Furospongin-1-en-10

Furospongin-1-en-10

C21H28O2 (312.2089188)


   

10-Chloro-1-heptadecene-4,6-diyne-3,8,9-triol

10-Chloro-1-heptadecene-4,6-diyne-3,8,9-triol

C17H25ClO3 (312.14921300000003)


   

(R)-p-cymen-9-yl beta-glucopyranoside

(R)-p-cymen-9-yl beta-glucopyranoside

C16H24O6 (312.1572804)


   
   

(12R)-4-methoxy-2-oxatricyclo[13.2.2.13,7]icosa-3,5,7(20),15,17,18-hexaen-12-ol|2-O-methyl acerogenin A|acerogenin 2-methyl ether|acerogenin A methyl ether

(12R)-4-methoxy-2-oxatricyclo[13.2.2.13,7]icosa-3,5,7(20),15,17,18-hexaen-12-ol|2-O-methyl acerogenin A|acerogenin 2-methyl ether|acerogenin A methyl ether

C20H24O3 (312.1725354)


   

3-(1,1-dimethylallyl)-8-(3,3-dimethylallyl)-7-methoxycoumarin

3-(1,1-dimethylallyl)-8-(3,3-dimethylallyl)-7-methoxycoumarin

C20H24O3 (312.1725354)


   

(3aS,5aR,12bS,12cR)-2,3,3a,4,5a,6,11,12,12b,12c-decahydro-3a,12b-dimethylfuro[3,2:5,6]cyclohepta[1,2:3,4]naphtho[1,8-bc]furan-7(1H)-one|limbatenolide A

(3aS,5aR,12bS,12cR)-2,3,3a,4,5a,6,11,12,12b,12c-decahydro-3a,12b-dimethylfuro[3,2:5,6]cyclohepta[1,2:3,4]naphtho[1,8-bc]furan-7(1H)-one|limbatenolide A

C20H24O3 (312.1725354)


   

(ent-12E)-15,16-Epoxy-1,3,12,13(16),14-clerodapentaen-18-oic acid

(ent-12E)-15,16-Epoxy-1,3,12,13(16),14-clerodapentaen-18-oic acid

C20H24O3 (312.1725354)


   

Cyclohexa-1,4-diene-3,6-dione, 1-(2-methylene-5,5,8a-trimethyldecalin-1-yl)methyl-

Cyclohexa-1,4-diene-3,6-dione, 1-(2-methylene-5,5,8a-trimethyldecalin-1-yl)methyl-

C21H28O2 (312.2089188)


   

18-Hydroxypregna-1,4,20-trien-3-one

18-Hydroxypregna-1,4,20-trien-3-one

C21H28O2 (312.2089188)


   

(2S,3R,4S,4aR,7S,7aS,3R,5R,Z)-2-(3,5-dimethylhept-1-enyl)-3,4-dihydroxy-7-methyl-4,4a,7,7a-tetrahydro-2H-furo[3,4-b]pyran-5(3H)-one|fusidilactone E

(2S,3R,4S,4aR,7S,7aS,3R,5R,Z)-2-(3,5-dimethylhept-1-enyl)-3,4-dihydroxy-7-methyl-4,4a,7,7a-tetrahydro-2H-furo[3,4-b]pyran-5(3H)-one|fusidilactone E

C17H28O5 (312.1936638)


   
   

(5R,7S,10S)-7alpha,16,7beta,20-diepoxycleistantha-8,11,13-trien-3-one|(5S,7S,10R)-7alpha,16-7beta,20-Diepoxycleistantha-8,11,13-trien-3-one|<5S,7S,10R>-7alpha,16: 7beta,20-diepoxycleistantha-8,11,13-triene-3-one

(5R,7S,10S)-7alpha,16,7beta,20-diepoxycleistantha-8,11,13-trien-3-one|(5S,7S,10R)-7alpha,16-7beta,20-Diepoxycleistantha-8,11,13-trien-3-one|<5S,7S,10R>-7alpha,16: 7beta,20-diepoxycleistantha-8,11,13-triene-3-one

C20H24O3 (312.1725354)


   

3-Ethyl-2,20-dioxabicyclo(14.3.1(eicosa-3,6,9,16,19-pentaen-12-yn-18-one

3-Ethyl-2,20-dioxabicyclo(14.3.1(eicosa-3,6,9,16,19-pentaen-12-yn-18-one

C20H24O3 (312.1725354)


   

4-O-Me 鈥樎?S)-Acerogenin A

4-O-Me 鈥樎?S)-Acerogenin A

C20H24O3 (312.1725354)


   

2-(4,8-dimethylnona-3,7-dienyl)-2-methylchromen-6-ol

2-(4,8-dimethylnona-3,7-dienyl)-2-methylchromen-6-ol

C21H28O2 (312.2089188)


   

Me ester-(+_)-2,5-Dihydro-2-methoxy-3,4-dimethyl-5-oxo-2-furannonanoic acid

Me ester-(+_)-2,5-Dihydro-2-methoxy-3,4-dimethyl-5-oxo-2-furannonanoic acid

C17H28O5 (312.1936638)


   

3alpha-Acetoxy-7-hydroxy-5beta-isobutyryloxy-carvotanacetone

3alpha-Acetoxy-7-hydroxy-5beta-isobutyryloxy-carvotanacetone

C16H24O6 (312.1572804)


   

3-methoxy-19-norpregna-1,3,5(10),20-tetraen-4-ol

3-methoxy-19-norpregna-1,3,5(10),20-tetraen-4-ol

C21H28O2 (312.2089188)


   

6-deoxo-5,6-didehydrolanugon Q

6-deoxo-5,6-didehydrolanugon Q

C20H24O3 (312.1725354)


   

7-O-methylkoninginin D

7-O-methylkoninginin D

C17H28O5 (312.1936638)


   

4,6-decadiyne-1-O-beta-D-glucopyranoside|carthamoside A2

4,6-decadiyne-1-O-beta-D-glucopyranoside|carthamoside A2

C16H24O6 (312.1572804)


   

1-(13-hydroxy-2,4,8-tetradecatrienoyl)glycerol

1-(13-hydroxy-2,4,8-tetradecatrienoyl)glycerol

C17H28O5 (312.1936638)


   
   

7a,8,10,11-tetrahydro-3,8,8,11a-tetramethyl-phenanthro(10,1bc)pyran5(4H),9(7H)-dione|<5S,7S,10S>-3-oxo-cleistantha-8,11,13-trien-(16 - 7beta)-olide|[5S,7S,10S]-3-oxo-cleistantha-8,11,13-trien-(16 - 7beta)-olide

7a,8,10,11-tetrahydro-3,8,8,11a-tetramethyl-phenanthro(10,1bc)pyran5(4H),9(7H)-dione|<5S,7S,10S>-3-oxo-cleistantha-8,11,13-trien-(16 - 7beta)-olide|[5S,7S,10S]-3-oxo-cleistantha-8,11,13-trien-(16 - 7beta)-olide

C20H24O3 (312.1725354)


   

de-O-ethylsalvonitin

de-O-ethylsalvonitin

C20H24O3 (312.1725354)


   

3,4,18beta-cyclopropa-14-oxo-ent-abieta-7,13,15-dien-16,12-olide|retusolide C

3,4,18beta-cyclopropa-14-oxo-ent-abieta-7,13,15-dien-16,12-olide|retusolide C

C20H24O3 (312.1725354)


   
   

(E)-methyl 3-[2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-2H-chromen-6-yl]acrylate|8-(3,3-dimethylallyl)wenteria chromene|8-<3,3-dimethylallyl>-werneria chromene

(E)-methyl 3-[2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-2H-chromen-6-yl]acrylate|8-(3,3-dimethylallyl)wenteria chromene|8-<3,3-dimethylallyl>-werneria chromene

C20H24O3 (312.1725354)


   
   

4-Carbomethoxyathrixianon|4-Methoxycarbonylathrixianone

4-Carbomethoxyathrixianon|4-Methoxycarbonylathrixianone

C20H24O3 (312.1725354)


   
   

1-Oxo-salvibretol

1-Oxo-salvibretol

C20H24O3 (312.1725354)


   
   

Artemotil

(1R,4S,5R,8S,9R,10S,12R,13R)-10-ethoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane

C17H28O5 (312.1936638)


Artemotil is an artemisinin derivative. Artemotil, also known as β-arteether, is a semi-synthetic derivative of artemisinin and a fast acting blood schizonticide specifically indicated for the treatment of chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria cases. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BE - Artemisinin and derivatives, plain D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides Artemotil (β-Arteether) has antimalarial activity for the treatment of chloroquine-resistant Plasmodium falciparum malaria with an IC50 of 1.61 nM. Artemotil also has central nervous system (CNS) neurotoxicity and anorectic toxicity in rats, dogs and monkeys[1][2]. Artemotil (β-Arteether) has antimalarial activity for the treatment of chloroquine-resistant Plasmodium falciparum malaria with an IC50 of 1.61 nM. Artemotil also has central nervous system (CNS) neurotoxicity and anorectic toxicity in rats, dogs and monkeys[1][2].

   

1-Oxomicrostegiol

1-Oxomicrostegiol

C20H24O3 (312.1725354)


   
   

praziquantel

Praziquantel (Biltricide)

C19H24N2O2 (312.18376839999996)


P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02B - Antitrematodals > P02BA - Quinoline derivatives and related substances D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent CONFIDENCE standard compound; INTERNAL_ID 164; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8927; ORIGINAL_PRECURSOR_SCAN_NO 8925 CONFIDENCE standard compound; INTERNAL_ID 164; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8934; ORIGINAL_PRECURSOR_SCAN_NO 8932 CONFIDENCE standard compound; INTERNAL_ID 164; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8954; ORIGINAL_PRECURSOR_SCAN_NO 8953 CONFIDENCE standard compound; INTERNAL_ID 164; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8977; ORIGINAL_PRECURSOR_SCAN_NO 8976 CONFIDENCE standard compound; INTERNAL_ID 164; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8993; ORIGINAL_PRECURSOR_SCAN_NO 8991 CONFIDENCE standard compound; INTERNAL_ID 2202 [Raw Data] CB144_Praziquantel_pos_50eV_CB000054.txt [Raw Data] CB144_Praziquantel_pos_40eV_CB000054.txt [Raw Data] CB144_Praziquantel_pos_30eV_CB000054.txt [Raw Data] CB144_Praziquantel_pos_20eV_CB000054.txt [Raw Data] CB144_Praziquantel_pos_10eV_CB000054.txt CONFIDENCE standard compound; EAWAG_UCHEM_ID 3272

   

Oseltamivir

Oseltamivir

C16H28N2O4 (312.20489680000003)


A cyclohexenecarboxylate ester that is the ethyl ester of oseltamivir acid. An antiviral prodrug (it is hydrolysed to the active free carboxylic acid in the liver), it is used to slow the spread of influenza. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AH - Neuraminidase inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong.

   

Levonorgestrel

(8R,9S,10R,13S,14S)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one

C21H28O2 (312.2089188)


D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

   

Ethisterone

17alpha-Ethynyl-17beta-hydroxyandrost-4-en-3-one

C21H28O2 (312.2089188)


A 17beta-hydroxy steroid that is testosterone in which the 17beta hydrogen is replaced by an ethynyl group. Ethisterone was the first orally active progestin and is a metabolite of danazol. G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03D - Progestogens > G03DC - Estren derivatives C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone ATC code: G03DC04

   

(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one

"(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one"

C21H28O2 (312.2089188)


   
   

MLS001076282-01!434-03-7

MLS001076282-01!434-03-7

C21H28O2 (312.2089188)


   

MLS001074069-01!D(-)-Norgestrel

MLS001074069-01!D(-)-Norgestrel

C21H28O2 (312.2089188)


   

MLS002153947-01!Dydrogesterone152-62-5

MLS002153947-01!Dydrogesterone152-62-5

C21H28O2 (312.2089188)


   

(3E,5S,8R,11E,13S,16R)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

NCGC00380335-01!(3E,5S,8R,11E,13S,16R)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1572804)


   

Norgestrel

(±)-13-ethyl-17α-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one

C21H28O2 (312.2089188)


G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AD - Emergency contraceptives G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AC - Progestogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents CONFIDENCE standard compound; INTERNAL_ID 282; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4987; ORIGINAL_PRECURSOR_SCAN_NO 4984 CONFIDENCE standard compound; INTERNAL_ID 282; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5650; ORIGINAL_PRECURSOR_SCAN_NO 5649 CONFIDENCE standard compound; INTERNAL_ID 282; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4969; ORIGINAL_PRECURSOR_SCAN_NO 4965 CONFIDENCE standard compound; INTERNAL_ID 282; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5035; ORIGINAL_PRECURSOR_SCAN_NO 5034 CONFIDENCE standard compound; INTERNAL_ID 282; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5762; ORIGINAL_PRECURSOR_SCAN_NO 5761 CONFIDENCE standard compound; INTERNAL_ID 282; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5116; ORIGINAL_PRECURSOR_SCAN_NO 5115 CONFIDENCE standard compound; INTERNAL_ID 282; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9309; ORIGINAL_PRECURSOR_SCAN_NO 9307 CONFIDENCE standard compound; INTERNAL_ID 282; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9321; ORIGINAL_PRECURSOR_SCAN_NO 9318 CONFIDENCE standard compound; INTERNAL_ID 282; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9409; ORIGINAL_PRECURSOR_SCAN_NO 9405 CONFIDENCE standard compound; INTERNAL_ID 282; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9359; ORIGINAL_PRECURSOR_SCAN_NO 9356 CONFIDENCE standard compound; INTERNAL_ID 282; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9374; ORIGINAL_PRECURSOR_SCAN_NO 9371 CONFIDENCE standard compound; INTERNAL_ID 282; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9442; ORIGINAL_PRECURSOR_SCAN_NO 9438 CONFIDENCE standard compound; INTERNAL_ID 2806 CONFIDENCE standard compound; INTERNAL_ID 8737

   

C11-LAS (STANDARD MIX)

C11-LAS (STANDARD MIX)

C17H28O3S (312.1759058)


Auto-extracted from standard mix; CONFIDENCE Tentative identification: isomers possible (Level 3)

   

C11-LAS (SAMPLE)

C11-LAS (SAMPLE)

C17H28O3S (312.1759058)


Auto-extracted from 130925_neg_10.mzML; CONFIDENCE Tentative identification: isomers possible (Level 3)

   

C16H24O6_beta-D-Glucopyranoside, 5-methyl-2-(1-methylethyl)phenyl

NCGC00380175-01_C16H24O6_beta-D-Glucopyranoside, 5-methyl-2-(1-methylethyl)phenyl

C16H24O6 (312.1572804)


   

16-Dehydroprogesterone

16-Dehydroprogesterone

C21H28O2 (312.2089188)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones 16-Dehydroprogesterone is a steroidal progestin.

   

granisetron

granisetron

C18H24N4O (312.19500139999997)


A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants > A04AA - Serotonin (5ht3) antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Granisetron (BRL 43694) is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy.

   

Thymol-beta-D-glucoside

Thymol-beta-D-glucoside

C16H24O6 (312.1572804)


   

Triptophenolide

Phenanthro(1,2-c)furan-1(3H)-one, 3b,4,5,9b,10,11-hexahydro-6-hydroxy-9b-methyl-7-(1-methylethyl)-, (3bR-trans)-

C20H24O3 (312.1725354)


Triptophenolide is a colorless crystalline plate isolated from ethyl acetate extracts of Tripterygium wilfordii. IC50 value: Target: In vitro: Triptophenolide can remarkably inhibit the delayed type hypersensitivity (DTH) reaction induced by DNCB and BSA; and diminished the peripheral blood ANAE+lymphocytes in rats and micc. Moreover, triptophenolide can dramatically increase the amount of total serum complement and significautly decrcase the serum antibody products (1gG ) of rats and mice. The phagocytosis of perioneal exudate macrophages in mice present double effects in vitro [1]. In vivo: Triptophenolide is a colorless crystalline plate isolated from ethyl acetate extracts of Tripterygium wilfordii. IC50 value: Target: In vitro: Triptophenolide can remarkably inhibit the delayed type hypersensitivity (DTH) reaction induced by DNCB and BSA; and diminished the peripheral blood ANAE+lymphocytes in rats and micc. Moreover, triptophenolide can dramatically increase the amount of total serum complement and significautly decrcase the serum antibody products (1gG ) of rats and mice. The phagocytosis of perioneal exudate macrophages in mice present double effects in vitro [1]. In vivo:

   
   
   

ethopropazine

Ethopropazine (oxide)

C19H24N2S (312.1660104)


   

3-Hydroxypsilotin

3-Hydroxypsilotin

C20H24O3 (312.1725354)


   

DL-Norgestrel

DL-Norgestrel

C21H28O2 (312.2089188)


CONFIDENCE standard compound; INTERNAL_ID 855; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5003; ORIGINAL_PRECURSOR_SCAN_NO 5002 CONFIDENCE standard compound; INTERNAL_ID 855; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5014; ORIGINAL_PRECURSOR_SCAN_NO 5011 CONFIDENCE standard compound; INTERNAL_ID 855; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5000; ORIGINAL_PRECURSOR_SCAN_NO 4999 CONFIDENCE standard compound; INTERNAL_ID 855; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4992; ORIGINAL_PRECURSOR_SCAN_NO 4991 CONFIDENCE standard compound; INTERNAL_ID 855; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4990; ORIGINAL_PRECURSOR_SCAN_NO 4989 CONFIDENCE standard compound; INTERNAL_ID 855; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4991; ORIGINAL_PRECURSOR_SCAN_NO 4990 CONFIDENCE standard compound; INTERNAL_ID 855; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9404; ORIGINAL_PRECURSOR_SCAN_NO 9401 CONFIDENCE standard compound; INTERNAL_ID 855; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9274; ORIGINAL_PRECURSOR_SCAN_NO 9272 CONFIDENCE standard compound; INTERNAL_ID 855; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9424; ORIGINAL_PRECURSOR_SCAN_NO 9422 CONFIDENCE standard compound; INTERNAL_ID 855; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9445; ORIGINAL_PRECURSOR_SCAN_NO 9444 CONFIDENCE standard compound; INTERNAL_ID 855; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9346; ORIGINAL_PRECURSOR_SCAN_NO 9344 CONFIDENCE standard compound; INTERNAL_ID 855; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9440; ORIGINAL_PRECURSOR_SCAN_NO 9438

   

Phenylalanylphenylalanine; AIF; CE0; CorrDec

Phenylalanylphenylalanine; AIF; CE0; CorrDec

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; AIF; CE10; CorrDec

Phenylalanylphenylalanine; AIF; CE10; CorrDec

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; AIF; CE30; CorrDec

Phenylalanylphenylalanine; AIF; CE30; CorrDec

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; AIF; CE0; MS2Dec

Phenylalanylphenylalanine; AIF; CE0; MS2Dec

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; AIF; CE10; MS2Dec

Phenylalanylphenylalanine; AIF; CE10; MS2Dec

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; AIF; CE30; MS2Dec

Phenylalanylphenylalanine; AIF; CE30; MS2Dec

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; LC-tDDA; CE10

Phenylalanylphenylalanine; LC-tDDA; CE10

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; LC-tDDA; CE20

Phenylalanylphenylalanine; LC-tDDA; CE20

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; LC-tDDA; CE30

Phenylalanylphenylalanine; LC-tDDA; CE30

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; LC-tDDA; CE40

Phenylalanylphenylalanine; LC-tDDA; CE40

C18H20N2O3 (312.147385)


   
   

Triptophenolide_major

Triptophenolide_major

C20H24O3 (312.1725354)


   

Triptophenolide_91.0\\%

Triptophenolide_91.0\\%

C20H24O3 (312.1725354)


   

Thymol-beta-D-glucoside_major

Thymol-beta-D-glucoside_major

C16H24O6 (312.1572804)


   

Triptophenolide_72.0\\%

Triptophenolide_72.0\\%

C20H24O3 (312.1725354)


   

h_82_Tetrahydrogestrinone

h_82_Tetrahydrogestrinone

C21H28O2 (312.2089188)


   
   

4-Hydroxyethinylestradiol

4-Hydroxyethinylestradiol

C20H24O3 (312.1725354)


   

2-hydroxyethinylestradiol

2-Hydroxy Ethynyl Estradiol

C20H24O3 (312.1725354)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

19-Norpregna-1,3,5(10)-trien-20-yne-3,6,17-triol, (6b,17a)-

19-Norpregna-1,3,5(10)-trien-20-yne-3,6,17-triol, (6b,17a)-

C20H24O3 (312.1725354)


   

17-Ethynylestriol

17a-Ethynylestriol

C20H24O3 (312.1725354)


   
   

6-Hydroxyethinylestradiol

6-Hydroxyethinylestradiol

C20H24O3 (312.1725354)


   
   
   

Z-Guggulsterone

(Z)-Guggulsterone

C21H28O2 (312.2089188)


(Z)-Guggulsterone, a constituent of Indian Ayurvedic medicinal plant Commiphora mukul, inhibits the growth of human prostate cancer cells by causing apoptosis. (Z)-Guggulsterone inhibits angiogenesis by suppressing the VEGF–VEGF-R2–Akt signaling axis[1]. (Z)-Guggulsterone is also a potent FXR antagonist. (Z)-Guggulsterone reduces ACE2 expression and SARS-CoV-2 infection[2]. (Z)-Guggulsterone, a constituent of Indian Ayurvedic medicinal plant Commiphora mukul, inhibits the growth of human prostate cancer cells by causing apoptosis. (Z)-Guggulsterone inhibits angiogenesis by suppressing the VEGF–VEGF-R2–Akt signaling axis[1]. (Z)-Guggulsterone is also a potent FXR antagonist. (Z)-Guggulsterone reduces ACE2 expression and SARS-CoV-2 infection[2].

   

(E)-guggulsterone

pregna-4-17(20)-diene-3,16-dione

C21H28O2 (312.2089188)


(-)-(E)-Guggulsterone is the metabolite of Z-guggulsterone. Guggulsterone is an active constituent of guggulipid, an ayurvedic agent derived from Commiphora mukul. Guggulsterone has hypolipidaemic activity[1]. (-)-(E)-Guggulsterone is the metabolite of Z-guggulsterone. Guggulsterone is an active constituent of guggulipid, an ayurvedic agent derived from Commiphora mukul. Guggulsterone has hypolipidaemic activity[1].

   

Tetrahydrogestrinone

(17a)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,9,11-trien-3-one

C21H28O2 (312.2089188)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens

   

Acitretin Ro 12-7310

Acitretin Ro 12-7310

C20H24O3 (312.1725354)


   

Apo-10'-bixinal

methyl (2E,4Z,6E,8E,10E,12E,14E)-4,8,13-trimethyl-16-oxohexadeca-2,4,6,8,10,12,14-heptaenoate

C20H24O3 (312.1725354)


   

Undecylbenzenesulfonic acid

4-Undecylbenzene-1-sulfonic acid

C17H28O3S (312.1759058)


   

Chloropanaxydiol

1-chloro-8-(3-heptyloxiran-2-yl)octa-4,6-diyne-2,3-diol

C17H25ClO3 (312.14921300000003)


   

7-(4-hydroxyphenyl)-5-methoxy-1-phenylheptan-3-one

7-(4-hydroxyphenyl)-5-methoxy-1-phenylheptan-3-one

C20H24O3 (312.1725354)


   

1-Phenyl-4-(2-phenylethyl)tetralin

1-phenyl-4-(2-phenylethyl)-1,2,3,4-tetrahydronaphthalene

C24H24 (312.1877904)


   

1-Phenyl-4-(1-phenylethyl)tetralin

1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene

C24H24 (312.1877904)


   

4'-Hydroxy-5,5'-diisopropyl-2,2'-dimethyl-3,4-biphenylquinone

4-[4-hydroxy-2-methyl-5-(propan-2-yl)phenyl]-3-methyl-6-(propan-2-yl)cyclohexa-3,5-diene-1,2-dione

C20H24O3 (312.1725354)


   

Thymolglucoside

2-Isopropyl-5-methylphenyl ?-D-glucopyranoside

C16H24O6 (312.1572804)


   

FA 17:3;O3

(7Z)-14-hydroxy-10,13-dioxo-7-heptadecenoic acid;cis-14-hydroxy-10,13-dioxo-7-heptadecenoic acid;cis-14-hydroxy-10,13-dioxoheptadec-7-enoic acid

C17H28O5 (312.1936638)


   

FOH 21:8;O

Henicosa-4E,10Z,12Z,20-tetraen-1,14-diyn-3,19-diol

C21H28O2 (312.2089188)


   

[4-(Dibenzylamino)phenyl]acetonitrile

[4-(Dibenzylamino)phenyl]acetonitrile

C22H20N2 (312.16264)


   

tert-Butyl 4-(phenylamino)piperidine-1-carboxylate hydrochloride

tert-Butyl 4-(phenylamino)piperidine-1-carboxylate hydrochloride

C16H25ClN2O2 (312.160446)


   
   

2-[(2-hydroxy-5-tert-butyl-phenyl)methyl]-4-tert-butyl-phenol

2-[(2-hydroxy-5-tert-butyl-phenyl)methyl]-4-tert-butyl-phenol

C21H28O2 (312.2089188)


   
   

4-(3,4,5-TRIMETHOXY-PHENYL)-2,3-DIHYDRO-1H-BENZO[B][1,4]DIAZEPINE

4-(3,4,5-TRIMETHOXY-PHENYL)-2,3-DIHYDRO-1H-BENZO[B][1,4]DIAZEPINE

C18H20N2O3 (312.147385)


   

4,4-Propane-2,2-diylbis(2-isopropylphenol)

4,4-Propane-2,2-diylbis(2-isopropylphenol)

C21H28O2 (312.2089188)


   

2-(2-(BENZYLOXY)-5-(TERT-BUTYL)PHENYL)-2-METHYLPROPAN-1-OL

2-(2-(BENZYLOXY)-5-(TERT-BUTYL)PHENYL)-2-METHYLPROPAN-1-OL

C21H28O2 (312.2089188)


   

4-[(2,6-Diisopropylphenoxy)methyl]phenylboronic acid

4-[(2,6-Diisopropylphenoxy)methyl]phenylboronic acid

C19H25BO3 (312.189665)


   

2-[(2,6-Diisopropylphenoxy)methyl]phenylboronic acid

2-[(2,6-Diisopropylphenoxy)methyl]phenylboronic acid

C19H25BO3 (312.189665)


   

Benzyl 2-butylpiperazine-1-carboxylate hydrochloride

Benzyl 2-butylpiperazine-1-carboxylate hydrochloride

C16H25ClN2O2 (312.160446)


   

4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]oxyaniline

4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]oxyaniline

C17H21BN2O3 (312.1645146000001)


   

N1-(2-Ethoxyphenyl)-N2-(2-ethylphenyl)oxalamide

N1-(2-Ethoxyphenyl)-N2-(2-ethylphenyl)oxalamide

C18H20N2O3 (312.147385)


   

6-Dehydroprogesterone

6-Dehydroprogesterone

C21H28O2 (312.2089188)


   

N,N-Dimethyl-1,1-binaphthalene-2,2-diamine

N,N-Dimethyl-1,1-binaphthalene-2,2-diamine

C22H20N2 (312.16264)


   

(R)-N,Nμ-Dimethyl-2,2μ-diamino-1,1μ-binaphthyl,(R)-N,Nμ-Dimethyl-1,1μ-binaphthalene-2,2μ-diamine

(R)-N,Nμ-Dimethyl-2,2μ-diamino-1,1μ-binaphthyl,(R)-N,Nμ-Dimethyl-1,1μ-binaphthalene-2,2μ-diamine

C22H20N2 (312.16264)


   

(S)-2-(tert-Butyldiphenylsilanyloxy)propionaldehyde

(S)-2-(tert-Butyldiphenylsilanyloxy)propionaldehyde

C19H24O2Si (312.15454839999995)


   

(+)-Norgestrel

(-)-N,N-DIMETHYLEPHEDRINIUMBROMIDE

C21H28O2 (312.2089188)


   

2-((4-Ethoxyphenyl)amino)-2-phenyl-N-propylacetamide

2-((4-Ethoxyphenyl)amino)-2-phenyl-N-propylacetamide

C19H24N2O2 (312.18376839999996)


   

4-[3-(4-hydroxy-3,5-dimethylphenyl)pentan-3-yl]-2,6-dimethylphenol

4-[3-(4-hydroxy-3,5-dimethylphenyl)pentan-3-yl]-2,6-dimethylphenol

C21H28O2 (312.2089188)


   

2-[ETHYL[4-[2-(4-NITROPHENYL)ETHENYL]PHENYL]AMINO]ETHANOL

2-[ETHYL[4-[2-(4-NITROPHENYL)ETHENYL]PHENYL]AMINO]ETHANOL

C18H20N2O3 (312.147385)


   

4-[1-(4-HYDROXY-3,5-DIMETHYLPHENYL)-1-METHYLBUTYL]-2,6-DIMETHYLPHENOL

4-[1-(4-HYDROXY-3,5-DIMETHYLPHENYL)-1-METHYLBUTYL]-2,6-DIMETHYLPHENOL

C21H28O2 (312.2089188)


   

4-cyclohexylphenol,formaldehyde,1,2-xylene

4-cyclohexylphenol,formaldehyde,1,2-xylene

C21H28O2 (312.2089188)


   

4-octylphenethyl methanesulfonate

4-octylphenethyl methanesulfonate

C17H28O3S (312.1759058)


   
   

5,6,14,15-DIBENZO-1,4-DIOXA-8,12-DIAZACYCLOPENTADECA-5,14-DIENE

5,6,14,15-DIBENZO-1,4-DIOXA-8,12-DIAZACYCLOPENTADECA-5,14-DIENE

C19H24N2O2 (312.18376839999996)


   

POLYIMIDAZOLINE, QUATERNIZED

POLYIMIDAZOLINE, QUATERNIZED

C14H24N4O4 (312.1797464)


   

Ethyl7-benzyl-4-hydroxy-5,6,7,8-tetrahydro-1,7-naphthyridine-3-carboxylate

Ethyl7-benzyl-4-hydroxy-5,6,7,8-tetrahydro-1,7-naphthyridine-3-carboxylate

C18H20N2O3 (312.147385)


   

2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazol[5,1-f][1,2,4]-triazin-4-one

2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazol[5,1-f][1,2,4]-triazin-4-one

C17H20N4O2 (312.158618)


   

3-hydroxy-2,2-dimethylpropyl 3-hydroxy-2,2-dimethylpropionate diacrylate

3-hydroxy-2,2-dimethylpropyl 3-hydroxy-2,2-dimethylpropionate diacrylate

C16H24O6 (312.1572804)


   

2-(BENZYLOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIMIDINE

2-(BENZYLOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIMIDINE

C17H21BN2O3 (312.1645146000001)


   

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-naphthoate

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-naphthoate

C18H21BO4 (312.1532816)


   
   

Demegestone

19-Norpregna-4,9-diene-3,20-dione,17-methyl-

C21H28O2 (312.2089188)


G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03D - Progestogens > G03DB - Pregnadien derivatives C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

   
   
   

2-(3-phenylmethoxyphenyl)octan-2-ol

2-(3-phenylmethoxyphenyl)octan-2-ol

C21H28O2 (312.2089188)


   

MESO-1,2-BIS(1-NAPHTHYL)ETHYLENEDIAMINE

MESO-1,2-BIS(1-NAPHTHYL)ETHYLENEDIAMINE

C22H20N2 (312.16264)


   

(3S,6S,8AS)-METHYL 6-((TERT-BUTOXYCARBONYL)AMINO)-5-OXOOCTAHYDROINDOLIZINE-3-CARBOXYLATE

(3S,6S,8AS)-METHYL 6-((TERT-BUTOXYCARBONYL)AMINO)-5-OXOOCTAHYDROINDOLIZINE-3-CARBOXYLATE

C15H24N2O5 (312.1685134)


   

2-Methyl-2-propanyl 7-(2-methoxy-2-oxoethyl)-6-oxo-1,7-diazaspiro [4.4]nonane-1-carboxylate

2-Methyl-2-propanyl 7-(2-methoxy-2-oxoethyl)-6-oxo-1,7-diazaspiro [4.4]nonane-1-carboxylate

C15H24N2O5 (312.1685134)


   

methyl 2-(4-benzylpiperazin-1-yl)pyrimidine-5-carboxylate

methyl 2-(4-benzylpiperazin-1-yl)pyrimidine-5-carboxylate

C17H20N4O2 (312.158618)


   

Tofacitinib

Tofacitinib

C16H20N6O (312.169851)


L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors > D000075242 - Janus Kinase Inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

(2-n-benzylaminoethyl)-3-aminopropyl-trimethoxysilane,tech-90

(2-n-benzylaminoethyl)-3-aminopropyl-trimethoxysilane,tech-90

C15H28N2O3Si (312.1869098)


   

1-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]-5-oxopyrrolidine-3-carboxylic acid

1-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]-5-oxopyrrolidine-3-carboxylic acid

C15H24N2O5 (312.1685134)


   

4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE

4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE

C19H24N2O2 (312.18376839999996)


   

2-Methyl-2-propanyl 4-[(2S)-2-(methoxycarbonyl)-1-pyrrolidinyl]-1 -piperidinecarboxylate

2-Methyl-2-propanyl 4-[(2S)-2-(methoxycarbonyl)-1-pyrrolidinyl]-1 -piperidinecarboxylate

C16H28N2O4 (312.20489680000003)


   

buta-1,3-diene,N-(hydroxymethyl)prop-2-enamide,prop-2-enenitrile,styrene

buta-1,3-diene,N-(hydroxymethyl)prop-2-enamide,prop-2-enenitrile,styrene

C19H24N2O2 (312.18376839999996)


   

[1,1-Binaphthalene]-2,2-diamine, N,N-dimethyl

[1,1-Binaphthalene]-2,2-diamine, N,N-dimethyl

C22H20N2 (312.16264)


   
   

1-(TERT-BUTOXYCARBONYL)-[1,4-BIPIPERIDINE]-4-CARBOXYLIC ACID

1-(TERT-BUTOXYCARBONYL)-[1,4-BIPIPERIDINE]-4-CARBOXYLIC ACID

C16H28N2O4 (312.20489680000003)


   

Titanium, Bu alc. iso-Pr alc. complexes

Titanium, Bu alc. iso-Pr alc. complexes

C14H32O4Ti (312.1779942)


   

(3R,4S)-Tofacitinib

(3R,4S)-Tofacitinib

C16H20N6O (312.169851)


   

(3S,4S)-Tofacitinib

(3S,4S)-Tofacitinib

C16H20N6O (312.169851)


   

(3S,4R)-Tofacitinib

(3S,4R)-Tofacitinib

C16H20N6O (312.169851)


   

(8R,9S,10R,13S,14S)-10,13-Dimethylspiro[7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-6,2-oxirane]-3,17(10H,14H)-dione

(8R,9S,10R,13S,14S)-10,13-Dimethylspiro[7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-6,2-oxirane]-3,17(10H,14H)-dione

C20H24O3 (312.1725354)


   

benzyl (2R)-2-butylpiperazine-1-carboxylate,hydrochloride

benzyl (2R)-2-butylpiperazine-1-carboxylate,hydrochloride

C16H25ClN2O2 (312.160446)


   

Molindone hydrochloride

(±)-Molindone Hydrochloride

C16H25ClN2O2 (312.160446)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Molindone hydrochloride (EN-1733A) is a therapeutic antipsychotic, used in the treatment of schizophrenia, works by blocking the effects of dopamine in the brain, leading to diminished psychoses.

   
   

Trenbolone Acetate

Trenbolone Acetate

C20H24O3 (312.1725354)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid

   
   

4-(PHENYLTHIO)OCTANOPHENONE

4-(PHENYLTHIO)OCTANOPHENONE

C20H24OS (312.1547774)


   

4-(4-heptoxyphenyl)benzoic acid

4-(4-heptoxyphenyl)benzoic acid

C20H24O3 (312.1725354)


   

N,N,N,N-TETRAMETHYL-N-[TRIS(DIMETHYLAMINO)PHOSPHORANYLIDENE]PHOSPHORIC TRIAMIDE

N,N,N,N-TETRAMETHYL-N-[TRIS(DIMETHYLAMINO)PHOSPHORANYLIDENE]PHOSPHORIC TRIAMIDE

C10H30N6OP2 (312.19562299999996)


   

Olanzapine Lactam Impurity

Olanzapine Lactam Impurity

C17H20N4O2 (312.158618)


   

Anastrozole Mono Acid

Anastrozole Mono Acid

C17H20N4O2 (312.158618)


   

Granisetronum

exo-Granisetron (Granisetron Impurity F)

C18H24N4O (312.19500139999997)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

4-(2,3-Difluoro-5-Methyl-phenyl)-piperazine-1-carboxylic acid tert-butyl ester

4-(2,3-Difluoro-5-Methyl-phenyl)-piperazine-1-carboxylic acid tert-butyl ester

C16H22F2N2O2 (312.1649256)


   

arteether

3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin, 10-ethoxydecahydro-3,6,9-trimethyl-

C17H28O5 (312.1936638)


   

trans-4-(Benzyloxycarbonylamino)cyclohexanemethylamine hydrochloride

trans-4-(Benzyloxycarbonylamino)cyclohexanemethylamine hydrochloride

C16H25ClN2O2 (312.160446)


   

Amides,coco, N-[3-(dimethylamino)propyl]

5-[3-(2,5-Dimethoxyphenyl)prop-1-Yn-1-Yl]-6-Ethylpyrimidine-2,4-Diamine

C17H20N4O2 (312.158618)


   

4-Chloro-4-(trans-4-propylcyclohexyl)-1,1-biphenyl

4-Chloro-4-(trans-4-propylcyclohexyl)-1,1-biphenyl

C21H25Cl (312.164468)


   

2,4-bis(dimethoxymethyl)-2,4-bis(hydroxymethyl)pentane-1,5-diol

2,4-bis(dimethoxymethyl)-2,4-bis(hydroxymethyl)pentane-1,5-diol

C13H28O8 (312.1784088)


   

2-ethylhexyl (4-chloro-2-methylphenoxy)acetate

2-ethylhexyl (4-chloro-2-methylphenoxy)acetate

C17H25ClO3 (312.14921300000003)


   

(R)-Benzyl 2-isobutylpiperazine-1-carboxylate hydrochloride

(R)-Benzyl 2-isobutylpiperazine-1-carboxylate hydrochloride

C16H25ClN2O2 (312.160446)


   

(S)-Benzyl 2-isobutylpiperazine-1-carboxylate hydrochloride

(S)-Benzyl 2-isobutylpiperazine-1-carboxylate hydrochloride

C16H25ClN2O2 (312.160446)


   

Benzoic acid, 4-methyl-, 4-(hexyloxy)phenyl ester

Benzoic acid, 4-methyl-, 4-(hexyloxy)phenyl ester

C20H24O3 (312.1725354)


   

methyl (3s,6s,8ar)-6-[(tert-butoxycarbonyl)amino]-5-oxooctahydroindolizine-3-carboxylate

methyl (3s,6s,8ar)-6-[(tert-butoxycarbonyl)amino]-5-oxooctahydroindolizine-3-carboxylate

C15H24N2O5 (312.1685134)


   

5-amino-2-nitrobenzoic acid

5-amino-2-nitrobenzoic acid

C20H24O3 (312.1725354)


   

4-(4-amino-3-methylnaphthalen-1-yl)-2-methylnaphthalen-1-amine

4-(4-amino-3-methylnaphthalen-1-yl)-2-methylnaphthalen-1-amine

C22H20N2 (312.16264)


   
   

(R)-1-N-BOC-2-BENZYLPIPERAZINE-HCl

(R)-1-N-BOC-2-BENZYLPIPERAZINE-HCl

C16H25ClN2O2 (312.160446)


   

(S)-1-N-BOC-2-BENZYL-PIPERAZINE-HCl

(S)-1-N-BOC-2-BENZYL-PIPERAZINE-HCl

C16H25ClN2O2 (312.160446)


   

benzyl (2S)-2-butylpiperazine-1-carboxylate,hydrochloride

benzyl (2S)-2-butylpiperazine-1-carboxylate,hydrochloride

C16H25ClN2O2 (312.160446)


   

(R)-Praziquantel

(R)-Praziquantel

C19H24N2O2 (312.18376839999996)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

   

2-(4-(1,1-Dimethylethyl)cyclohexyl)-3-hydroxy-1,4-naphthalenedione

2-(4-(1,1-Dimethylethyl)cyclohexyl)-3-hydroxy-1,4-naphthalenedione

C20H24O3 (312.1725354)


   

Etidocaine hydrochloride

Etidocaine hydrochloride

C17H29ClN2O (312.1968294)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(5-isopropyl-2-methylphenoxy)tetrahydro-2H-pyran-3,4,5-triol

(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(5-isopropyl-2-methylphenoxy)tetrahydro-2H-pyran-3,4,5-triol

C16H24O6 (312.1572804)


   

2-[3-(2-Hydroxyethoxy)-2,2-bis(2-hydroxyethoxymethyl)propoxy]ethanol

2-[3-(2-Hydroxyethoxy)-2,2-bis(2-hydroxyethoxymethyl)propoxy]ethanol

C13H28O8 (312.1784088)


   
   

17-Vinylestradiol 3-methyl ether

3-Methoxy-19-nor-17alpha-pregna-1,3,5(10),20-tetraen-17-ol

C21H28O2 (312.2089188)


   
   

3-Methoxy-19-norpregna-1,3,5(10)-trien-20-one

3-Methoxy-19-norpregna-1,3,5(10)-trien-20-one

C21H28O2 (312.2089188)


   

N-[2-[(3-cyano-6-ethoxy-2-quinolinyl)amino]ethyl]propanamide

N-[2-[(3-cyano-6-ethoxy-2-quinolinyl)amino]ethyl]propanamide

C17H20N4O2 (312.158618)


   

1,2-Diphenyltryptamine

1,2-Diphenyltryptamine

C22H20N2 (312.16264)


   

6,7,8,13,14,15-Hexahydro-7,14-methanobenzo[6,7]cyclodeca[1,2-b]naphthalen-17-one

6,7,8,13,14,15-Hexahydro-7,14-methanobenzo[6,7]cyclodeca[1,2-b]naphthalen-17-one

C23H20O (312.151407)


   

(2E,4E,6E,8E)-9-(4-hydroxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid

(2E,4E,6E,8E)-9-(4-hydroxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid

C20H24O3 (312.1725354)


D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

   

5,6,7,8,9,10-Hexahydro-4-hydroxy-3-(1-phenylpropyl)cycloocta[B]pyran-2-one

5,6,7,8,9,10-Hexahydro-4-hydroxy-3-(1-phenylpropyl)cycloocta[B]pyran-2-one

C20H24O3 (312.1725354)


   

Profenamine

ethopropazine

C19H24N2S (312.1660104)


N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   

propamidine

propamidine

C17H20N4O2 (312.158618)


D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AC - Biguanides and amidines D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives

   

guggulsterone

(8R,9S,10R,13S,14S,17E)-17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-quinone

C21H28O2 (312.2089188)


(-)-(E)-Guggulsterone is the metabolite of Z-guggulsterone. Guggulsterone is an active constituent of guggulipid, an ayurvedic agent derived from Commiphora mukul. Guggulsterone has hypolipidaemic activity[1]. (-)-(E)-Guggulsterone is the metabolite of Z-guggulsterone. Guggulsterone is an active constituent of guggulipid, an ayurvedic agent derived from Commiphora mukul. Guggulsterone has hypolipidaemic activity[1]. Guggulsterone is a plant sterol derived from the gum resin of the tree Commiphora wightii. Guggulsterone inhibits the growth of a wide variety of tumor cells and induces apoptosis through down regulation of antiapoptotic gene products (IAP1, xIAP, Bfl-1/A1, Bcl-2, cFLIP and survivin), modulation of cell cycle proteins (cyclin D1 and c-Myc), activation of caspases and JNK, inhibition of Akt[1]. Guggulsterone, a farnesoid X receptor (FXR) antagonist, decreases CDCA-induced FXR activation with IC50s of 17 and 15 μM for Z- and E-Guggulsterone, respectively[2]. Guggulsterone is a plant sterol derived from the gum resin of the tree Commiphora wightii. Guggulsterone inhibits the growth of a wide variety of tumor cells and induces apoptosis through down regulation of antiapoptotic gene products (IAP1, xIAP, Bfl-1/A1, Bcl-2, cFLIP and survivin), modulation of cell cycle proteins (cyclin D1 and c-Myc), activation of caspases and JNK, inhibition of Akt[1]. Guggulsterone, a farnesoid X receptor (FXR) antagonist, decreases CDCA-induced FXR activation with IC50s of 17 and 15 μM for Z- and E-Guggulsterone, respectively[2]. Guggulsterone is a plant sterol derived from the gum resin of the tree Commiphora wightii. Guggulsterone inhibits the growth of a wide variety of tumor cells and induces apoptosis through down regulation of antiapoptotic gene products (IAP1, xIAP, Bfl-1/A1, Bcl-2, cFLIP and survivin), modulation of cell cycle proteins (cyclin D1 and c-Myc), activation of caspases and JNK, inhibition of Akt[1]. Guggulsterone, a farnesoid X receptor (FXR) antagonist, decreases CDCA-induced FXR activation with IC50s of 17 and 15 μM for Z- and E-Guggulsterone, respectively[2].

   

Yakuchinone A

3-Heptanone, 1-(4-hydroxy-3-methoxyphenyl)-7-phenyl-

C20H24O3 (312.1725354)


Yakuchinone A is a natural product isolated from the fruit of Alpinia oxyphylla, which can induce apoptosis and has anticancer and anti-inflammatory activities[1]. Yakuchinone A is a natural product isolated from the fruit of Alpinia oxyphylla, which can induce apoptosis and has anticancer and anti-inflammatory activities[1].

   

5-(4-Sulfophenyl)undecane

5-(4-Sulfophenyl)undecane

C17H28O3S (312.1759058)


   

Glucopyranoside,2-ipr-5-ME phenyl

Glucopyranoside,2-ipr-5-ME phenyl

C16H24O6 (312.1572804)


   

tibolone

14-ethynyl-14-hydroxy-9,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-2(7)-en-5-one

C21H28O2 (312.2089188)


   

Thebaine(1+)

Thebaine(1+)

C19H22NO3+ (312.1599602)


The trialkylammonium ion resulting from the protonation of the amino group of thebaine.

   

4beta-Acetoxy-10beta,15alpha-dihydroxyprobotryane

4beta-Acetoxy-10beta,15alpha-dihydroxyprobotryane

C17H28O5 (312.1936638)


   

(9R,10S,12S,13S,14R,16S,18R)-13-ethyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol

(9R,10S,12S,13S,14R,16S,18R)-13-ethyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol

C19H24N2O2 (312.18376839999996)


   

(17E)-17-Ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione

(17E)-17-Ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione

C21H28O2 (312.2089188)


   

beta-D-Glucopyranoside, 5-methyl-2-(1-methylethyl)phenyl

beta-D-Glucopyranoside, 5-methyl-2-(1-methylethyl)phenyl

C16H24O6 (312.1572804)


   

Pregna-4,11-diene-3,20-dione

Pregna-4,11-diene-3,20-dione

C21H28O2 (312.2089188)


   

Anhydrofurospongin-1

Anhydrofurospongin-1

C21H28O2 (312.2089188)


A natural product found in Spongia officinalis.

   

1-methyl-N-[(1S,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]-3-indazolecarboxamide

1-methyl-N-[(1S,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]-3-indazolecarboxamide

C18H24N4O (312.19500139999997)


   

(3,5-dimethylphenyl)[4-(3-ethyl-4H-1,2,4-triazol-4-yl)piperidino]methanone

(3,5-dimethylphenyl)[4-(3-ethyl-4H-1,2,4-triazol-4-yl)piperidino]methanone

C18H24N4O (312.19500139999997)


   

2,3-dimethoxy-N-[4-(1-piperidinyl)phenyl]aniline

2,3-dimethoxy-N-[4-(1-piperidinyl)phenyl]aniline

C19H24N2O2 (312.18376839999996)


   

2-[(3R,6aS,8R,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3R,6aS,8R,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

2-[(3R,6aS,8S,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3R,6aS,8S,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

(2S,3E)-4-[(4aR,5aS,9R,10aR,11S,11aS)-11-hydroxy-2,3,4,4a,5a,6,9,10a,11,11a-decahydropyrano[2,3:5,6]pyrano[3,2-b]oxepin-9-yl]but-3-ene-1,2-diol

(2S,3E)-4-[(4aR,5aS,9R,10aR,11S,11aS)-11-hydroxy-2,3,4,4a,5a,6,9,10a,11,11a-decahydropyrano[2,3:5,6]pyrano[3,2-b]oxepin-9-yl]but-3-ene-1,2-diol

C16H24O6 (312.1572804)


   

2-[(3S,6aR,8S,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3S,6aR,8S,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

2-[(3S,6aS,8S,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3S,6aS,8S,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

2-[(3R,6aR,8R,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3R,6aR,8R,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

(6S,7S,8S)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8S)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H24N2O2 (312.18376839999996)


   

(6S,7S,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H24N2O2 (312.18376839999996)


   

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

2-[(3S,6aS,8R,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3S,6aS,8R,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

(6R,7S,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H24N2O2 (312.18376839999996)


   

(6R,7R,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H24N2O2 (312.18376839999996)


   

(6S,7R,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H24N2O2 (312.18376839999996)


   

(6R,7R,8S)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8S)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H24N2O2 (312.18376839999996)


   

1-{4-[(2-Hydroxyethyl)carbamoyl]benzyl}-1-methylpiperidinium chloride

1-{4-[(2-Hydroxyethyl)carbamoyl]benzyl}-1-methylpiperidinium chloride

C16H25ClN2O2 (312.160446)


   

(10S,13R,17E)-17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione

(10S,13R,17E)-17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione

C21H28O2 (312.2089188)


   

(8S,9R,10S,13R,14R,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one

(8S,9R,10S,13R,14R,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one

C21H28O2 (312.2089188)


   

6-(4-Phenylpiperazino)hexanoic acid hydrochloride

6-(4-Phenylpiperazino)hexanoic acid hydrochloride

C16H25ClN2O2 (312.160446)


   

(1R,9R,10S,12R,13S,14R,17S,18R)-13-ethyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol

(1R,9R,10S,12R,13S,14R,17S,18R)-13-ethyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol

C19H24N2O2 (312.18376839999996)


   
   

Levonorgestrel (Levonelle)

Levonorgestrel (Levonelle)

C21H28O2 (312.2089188)


   

17beta-Hydroxyestra-4,9,11-trien-3-one, acetate

17beta-Hydroxyestra-4,9,11-trien-3-one, acetate

C20H24O3 (312.1725354)


   

5-Methyl-4,4-pentamethylene-2-para-tolylpephydropyrrolo(3,4-C)pyrrole-1,3-dione

5-Methyl-4,4-pentamethylene-2-para-tolylpephydropyrrolo(3,4-C)pyrrole-1,3-dione

C19H24N2O2 (312.18376839999996)


   

3-[(2-Oxo)-2-morpholinoethylamino]-4-methyl-6-phenylpyridazine

3-[(2-Oxo)-2-morpholinoethylamino]-4-methyl-6-phenylpyridazine

C17H20N4O2 (312.158618)


   

(8R,9R,10R,13S,14S,17S)-17-ethynyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one

(8R,9R,10R,13S,14S,17S)-17-ethynyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one

C21H28O2 (312.2089188)


   

(3S,4S)-5-Benzyloxy-3-(2-methoxyethoxymethoxy)-4-methylpentan-2-ol

(3S,4S)-5-Benzyloxy-3-(2-methoxyethoxymethoxy)-4-methylpentan-2-ol

C17H28O5 (312.1936638)


   

3-Ethoxy-6-(5-methyl-1-methylthiomethoxy-4-hexenyl)-2-cyclohexen-1-one

3-Ethoxy-6-(5-methyl-1-methylthiomethoxy-4-hexenyl)-2-cyclohexen-1-one

C17H28O3S (312.1759058)


   

Isopropyl 2-(N-((4S)-4-(1-methylethyl)-2-oxazolidinone-3-carbamoyl)amino)-4-pentenoate

Isopropyl 2-(N-((4S)-4-(1-methylethyl)-2-oxazolidinone-3-carbamoyl)amino)-4-pentenoate

C15H24N2O5 (312.1685134)


   

Yakuchinone A

3-Heptanone, 1-(4-hydroxy-3-methoxyphenyl)-7-phenyl-

C20H24O3 (312.1725354)


1-(4-hydroxy-3-methoxyphenyl)-7-phenyl-3-heptanone is a ketone that is heptan-3-one substituted by a 4-hydroxy-3-methoxyphenyl group at position 1 and a phenyl group at position 7. Isolated from in Alpinia oxyphylla, it exhibits antineoplastic and inhibitory activities against COX-1, COX-2 and NO synthase. It has a role as a metabolite, a cyclooxygenase 1 inhibitor, a cyclooxygenase 2 inhibitor, an EC 1.14.13.39 (nitric oxide synthase) inhibitor and an antineoplastic agent. It is a monomethoxybenzene, a member of phenols and a ketone. Yakuchinone-A is a natural product found in Alpinia oxyphylla with data available. A ketone that is heptan-3-one substituted by a 4-hydroxy-3-methoxyphenyl group at position 1 and a phenyl group at position 7. Isolated from in Alpinia oxyphylla, it exhibits antineoplastic and inhibitory activities against COX-1, COX-2 and NO synthase. Yakuchinone A is a natural product isolated from the fruit of Alpinia oxyphylla, which can induce apoptosis and has anticancer and anti-inflammatory activities[1]. Yakuchinone A is a natural product isolated from the fruit of Alpinia oxyphylla, which can induce apoptosis and has anticancer and anti-inflammatory activities[1].

   

4-Undecylbenzenesulfonic acid

4-Undecylbenzenesulfonic acid

C17H28O3S (312.1759058)


   

2,4,6-Triphenyl-1-hexene

1,5-diphenylhex-5-en-3-ylbenzene

C24H24 (312.1877904)


   

4-Hydroxy-5,5-diisopropyl-2,2-dimethyl-3,4-biphenylquinone

4-Hydroxy-5,5-diisopropyl-2,2-dimethyl-3,4-biphenylquinone

C20H24O3 (312.1725354)


   

1-chloro-8-(3-heptyloxiran-2-yl)octa-4,6-diyne-2,3-diol

1-chloro-8-(3-heptyloxiran-2-yl)octa-4,6-diyne-2,3-diol

C17H25ClO3 (312.14921300000003)


   

5-Methoxy-7-(4-hydroxyphenyl)-1-phenyl-3-heptanone

5-Methoxy-7-(4-hydroxyphenyl)-1-phenyl-3-heptanone

C20H24O3 (312.1725354)


   

Methyl (9Z)-10-oxo-6,10-diapo-6-carotenoate

Methyl (9Z)-10-oxo-6,10-diapo-6-carotenoate

C20H24O3 (312.1725354)


   

1,3,5-Triphenylcyclohexane

1,1,1-(1,3,5-Cyclohexanetriyl)tribenzene

C24H24 (312.1877904)


   

1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene

1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene

C24H24 (312.1877904)


   

1-phenyl-4-(2-phenylethyl)-1,2,3,4-tetrahydronaphthalene

1-phenyl-4-(2-phenylethyl)-1,2,3,4-tetrahydronaphthalene

C24H24 (312.1877904)


   

pregna-4,9(11)-diene-3,20-dione

pregna-4,9(11)-diene-3,20-dione

C21H28O2 (312.2089188)


   

11-Dehydroprogesterone

Pregna-4,11-diene-3,20-dione

C21H28O2 (312.2089188)


   

(7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid

(7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid

C17H28O5 (312.1936638)


A monounsaturated fatty acid that is (7Z)-heptadec-7-enoic acid which is substituted by a hydroxy group at position 14 and by oxo groups at positions 10 and 13.

   

5,13-Dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

5,13-Dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1572804)


   
   

Hydroxyethinylestradiol

Hydroxyethinylestradiol

C20H24O3 (312.1725354)


   

Didehydro-progesterone

Didehydro-progesterone

C21H28O2 (312.2089188)


   

RSVA405

RSVA405

C17H20N4O2 (312.158618)


RSVA405 is a potent, orally active activator of AMPK, with an EC50 of 1 μM. RSVA405 facilitates CaMKKβ-dependent activation of AMPK, inhibits mTOR, and promotes autophagy to increase Aβ degradation. RSVA405 has anti-inflammatory effects through the inhibition of STAT3 function. RSVA405 can also be used for the research of obesity[1][2][3][4].

   

methyl (2e)-3-[2,2-dimethyl-8-(3-methylbut-2-en-1-yl)chromen-6-yl]prop-2-enoate

methyl (2e)-3-[2,2-dimethyl-8-(3-methylbut-2-en-1-yl)chromen-6-yl]prop-2-enoate

C20H24O3 (312.1725354)


   

(2r)-2,3-dihydroxypropyl (2e,4e,8e,13s)-13-hydroxytetradeca-2,4,8-trienoate

(2r)-2,3-dihydroxypropyl (2e,4e,8e,13s)-13-hydroxytetradeca-2,4,8-trienoate

C17H28O5 (312.1936638)


   

2,3,11-trihydroxy-4,6,6,10-tetramethyltricyclo[5.3.1.0⁴,¹¹]undecan-8-yl acetate

2,3,11-trihydroxy-4,6,6,10-tetramethyltricyclo[5.3.1.0⁴,¹¹]undecan-8-yl acetate

C17H28O5 (312.1936638)


   

2,4b,8,8a-tetramethyl-10-oxo-6,9-dihydro-5h-phenanthren-3-yl acetate

2,4b,8,8a-tetramethyl-10-oxo-6,9-dihydro-5h-phenanthren-3-yl acetate

C20H24O3 (312.1725354)


   

n-hexyl-2-hydroxy-n-[3-(2-oxo-5h-furan-3-yl)propanoyl]ethanehydrazonic acid

n-hexyl-2-hydroxy-n-[3-(2-oxo-5h-furan-3-yl)propanoyl]ethanehydrazonic acid

C15H24N2O5 (312.1685134)


   

(3s)-3-[(2s,4r,5s)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-3-(2-hydroxyethyl)indol-2-ol

(3s)-3-[(2s,4r,5s)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-3-(2-hydroxyethyl)indol-2-ol

C19H24N2O2 (312.18376839999996)


   

(3s,6s)-6-[(1s,4r)-4-hydroperoxy-4-methylcyclohex-2-en-1-yl]-2,2,6-trimethyloxan-3-yl acetate

(3s,6s)-6-[(1s,4r)-4-hydroperoxy-4-methylcyclohex-2-en-1-yl]-2,2,6-trimethyloxan-3-yl acetate

C17H28O5 (312.1936638)


   

(2s,5s,7r,8s,17s)-2,7,14-trimethyl-16-oxapentacyclo[9.7.0.0²,⁸.0⁵,⁷.0¹³,¹⁷]octadeca-1(11),13-diene-12,15-dione

(2s,5s,7r,8s,17s)-2,7,14-trimethyl-16-oxapentacyclo[9.7.0.0²,⁸.0⁵,⁷.0¹³,¹⁷]octadeca-1(11),13-diene-12,15-dione

C20H24O3 (312.1725354)


   

(3s,5r,7s,8r)-7,8-dihydroxy-5-(2-hydroxypropan-2-yl)-11,11-dimethyl-4,10-dioxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-13-one

(3s,5r,7s,8r)-7,8-dihydroxy-5-(2-hydroxypropan-2-yl)-11,11-dimethyl-4,10-dioxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-13-one

C16H24O6 (312.1572804)


   

(10ar)-5,6-dihydroxy-7-isopropyl-1,1,10a-trimethyl-2h-phenanthren-3-one

(10ar)-5,6-dihydroxy-7-isopropyl-1,1,10a-trimethyl-2h-phenanthren-3-one

C20H24O3 (312.1725354)


   

(2r,6as,7r,10ar)-2-hydroxy-2,5-dimethyl-10-methylidene-7-(prop-1-en-2-yl)-3h,6ah,7h,8h,9h,10ah-cyclohexa[e]azulene-1,4-dione

(2r,6as,7r,10ar)-2-hydroxy-2,5-dimethyl-10-methylidene-7-(prop-1-en-2-yl)-3h,6ah,7h,8h,9h,10ah-cyclohexa[e]azulene-1,4-dione

C20H24O3 (312.1725354)


   

2-(3-ethenylpiperidin-4-yl)-1-[3-(2-hydroxyethyl)-1h-indol-2-yl]ethanone

2-(3-ethenylpiperidin-4-yl)-1-[3-(2-hydroxyethyl)-1h-indol-2-yl]ethanone

C19H24N2O2 (312.18376839999996)


   

(2r,3s)-2,3,9-trimethyl-2-(4-methylpent-3-en-1-yl)-3h-furo[3,2-c]chromen-4-one

(2r,3s)-2,3,9-trimethyl-2-(4-methylpent-3-en-1-yl)-3h-furo[3,2-c]chromen-4-one

C20H24O3 (312.1725354)


   

2-{[(6r)-2,6-dimethyl-6-[(1e)-4-methylpenta-1,3-dien-1-yl]cyclohex-1-en-1-yl]methyl}benzene-1,4-diol

2-{[(6r)-2,6-dimethyl-6-[(1e)-4-methylpenta-1,3-dien-1-yl]cyclohex-1-en-1-yl]methyl}benzene-1,4-diol

C21H28O2 (312.2089188)


   

3-[2-(3-ethyl-1-methylpiperidin-4-ylidene)ethylidene]-7-methoxy-1h-indol-2-one

3-[2-(3-ethyl-1-methylpiperidin-4-ylidene)ethylidene]-7-methoxy-1h-indol-2-one

C19H24N2O2 (312.18376839999996)


   

(1s,2r,7s,8r,17r)-2,7,14-trimethyl-16-oxapentacyclo[9.7.0.0²,⁸.0⁵,⁷.0¹³,¹⁷]octadeca-10,13-diene-12,15-dione

(1s,2r,7s,8r,17r)-2,7,14-trimethyl-16-oxapentacyclo[9.7.0.0²,⁸.0⁵,⁷.0¹³,¹⁷]octadeca-10,13-diene-12,15-dione

C20H24O3 (312.1725354)


   

(3z)-3-{2-[(3s,4z)-3-ethyl-1-methylpiperidin-4-ylidene]ethylidene}-7-methoxyindol-2-ol

(3z)-3-{2-[(3s,4z)-3-ethyl-1-methylpiperidin-4-ylidene]ethylidene}-7-methoxyindol-2-ol

C19H24N2O2 (312.18376839999996)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(2,3,4-trimethylphenyl)methoxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(2,3,4-trimethylphenyl)methoxy]oxane-3,4,5-triol

C16H24O6 (312.1572804)


   

2-{[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}cyclohexa-2,5-diene-1,4-dione

2-{[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}cyclohexa-2,5-diene-1,4-dione

C21H28O2 (312.2089188)


   

12-ethyl-4,11-dihydroxy-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione

12-ethyl-4,11-dihydroxy-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione

C17H28O5 (312.1936638)


   

2-[(1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl)methyl]cyclohexa-2,5-diene-1,4-dione

2-[(1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl)methyl]cyclohexa-2,5-diene-1,4-dione

C21H28O2 (312.2089188)


   

2,7,14-trimethyl-16-oxapentacyclo[9.7.0.0²,⁸.0⁵,⁷.0¹³,¹⁷]octadeca-10,13-diene-12,15-dione

2,7,14-trimethyl-16-oxapentacyclo[9.7.0.0²,⁸.0⁵,⁷.0¹³,¹⁷]octadeca-10,13-diene-12,15-dione

C20H24O3 (312.1725354)


   

(4ar)-5-hydroxy-7-isopropyl-1,1,4a-trimethyl-2,4-dihydrophenanthrene-3,6-dione

(4ar)-5-hydroxy-7-isopropyl-1,1,4a-trimethyl-2,4-dihydrophenanthrene-3,6-dione

C20H24O3 (312.1725354)


   

(3s)-3-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-3-(2-hydroxyethyl)indol-2-ol

(3s)-3-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-3-(2-hydroxyethyl)indol-2-ol

C19H24N2O2 (312.18376839999996)


   

(7s)-7-[2-(furan-3-yl)ethyl]-6,7-dimethyl-3h,4h,5h,6h-cyclodeca[c]furan-1-one

(7s)-7-[2-(furan-3-yl)ethyl]-6,7-dimethyl-3h,4h,5h,6h-cyclodeca[c]furan-1-one

C20H24O3 (312.1725354)


   

(3z,5s,11e,13r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

(3z,5s,11e,13r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1572804)


   

6-(4-hydroperoxy-4-methylcyclohex-2-en-1-yl)-2,2,6-trimethyloxan-3-yl acetate

6-(4-hydroperoxy-4-methylcyclohex-2-en-1-yl)-2,2,6-trimethyloxan-3-yl acetate

C17H28O5 (312.1936638)


   

15-(2-hydroxyethyl)-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-ol

15-(2-hydroxyethyl)-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-ol

C19H24N2O2 (312.18376839999996)


   

(3e,7e,11z,14s)-4,8,12-trimethylbicyclo[12.2.2]octadeca-1(16),3,7,11-tetraene-15,17-dione

(3e,7e,11z,14s)-4,8,12-trimethylbicyclo[12.2.2]octadeca-1(16),3,7,11-tetraene-15,17-dione

C21H28O2 (312.2089188)


   

(2r,3r,6as,7r,10ar)-3-hydroxy-2,5-dimethyl-10-methylidene-7-(prop-1-en-2-yl)-2h,3h,6ah,7h,8h,9h,10ah-cyclohexa[e]azulene-1,4-dione

(2r,3r,6as,7r,10ar)-3-hydroxy-2,5-dimethyl-10-methylidene-7-(prop-1-en-2-yl)-2h,3h,6ah,7h,8h,9h,10ah-cyclohexa[e]azulene-1,4-dione

C20H24O3 (312.1725354)


   

(9e)-12-ethyl-4,11-dihydroxy-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione

(9e)-12-ethyl-4,11-dihydroxy-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione

C17H28O5 (312.1936638)


   

7-hydroxy-2-methyl-6,8-bis(3-methylbut-2-en-1-yl)chromen-4-one

7-hydroxy-2-methyl-6,8-bis(3-methylbut-2-en-1-yl)chromen-4-one

C20H24O3 (312.1725354)


   

2-(3,5-dimethylhept-1-en-1-yl)-3,4-dihydroxy-7-methyl-hexahydrofuro[3,4-b]pyran-5-one

2-(3,5-dimethylhept-1-en-1-yl)-3,4-dihydroxy-7-methyl-hexahydrofuro[3,4-b]pyran-5-one

C17H28O5 (312.1936638)


   

2-(3,4,8-trihydroxy-3,8-dimethyl-octahydroazulen-5-yl)prop-2-en-1-yl acetate

2-(3,4,8-trihydroxy-3,8-dimethyl-octahydroazulen-5-yl)prop-2-en-1-yl acetate

C17H28O5 (312.1936638)


   

2-(hydroxymethyl)-6-[2-(4-methylphenyl)propoxy]oxane-3,4,5-triol

2-(hydroxymethyl)-6-[2-(4-methylphenyl)propoxy]oxane-3,4,5-triol

C16H24O6 (312.1572804)


   

2-[(5s,7s)-1,1,7-trimethyl-6-methylidene-3,4,5,7,8,9-hexahydro-2h-benzo[7]annulen-5-yl]benzene-1,4-diol

2-[(5s,7s)-1,1,7-trimethyl-6-methylidene-3,4,5,7,8,9-hexahydro-2h-benzo[7]annulen-5-yl]benzene-1,4-diol

C21H28O2 (312.2089188)


   

(2r,15r,16s,18r)-15-ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.0⁴,¹².0⁵,¹⁰.0¹⁶,¹⁸]icosa-4(12),5,7,9-tetraen-2-ol

(2r,15r,16s,18r)-15-ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.0⁴,¹².0⁵,¹⁰.0¹⁶,¹⁸]icosa-4(12),5,7,9-tetraen-2-ol

C19H24N2O2 (312.18376839999996)


   

7-(4-hydroxy-3-methoxyphenyl)-1-phenylheptan-3-one

7-(4-hydroxy-3-methoxyphenyl)-1-phenylheptan-3-one

C20H24O3 (312.1725354)


   

(1r,10s,11s)-6-ethyl-5,11-dimethyl-14-oxatetracyclo[9.3.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-triene-8,12-dione

(1r,10s,11s)-6-ethyl-5,11-dimethyl-14-oxatetracyclo[9.3.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-triene-8,12-dione

C20H24O3 (312.1725354)


   

7-hydroxy-7-(6-hydroxy-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-2-yl)heptanoic acid

7-hydroxy-7-(6-hydroxy-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-2-yl)heptanoic acid

C16H24O6 (312.1572804)


   

(1e,3z,6r,7r)-6-[(1e)-2-(furan-3-yl)ethenyl]-6,7-dimethyl-10-methylidenecyclodeca-1,3-diene-1-carboxylic acid

(1e,3z,6r,7r)-6-[(1e)-2-(furan-3-yl)ethenyl]-6,7-dimethyl-10-methylidenecyclodeca-1,3-diene-1-carboxylic acid

C20H24O3 (312.1725354)


   

(2r)-2-hydroxy-1-(7-hydroxy-6-isopropyl-2-methylnaphthalen-1-yl)-4-methylpent-3-en-1-one

(2r)-2-hydroxy-1-(7-hydroxy-6-isopropyl-2-methylnaphthalen-1-yl)-4-methylpent-3-en-1-one

C20H24O3 (312.1725354)


   

(1r,3ar,4s,6r)-1,4,7-trimethyl-6-(2-methylprop-1-en-1-yl)-1h,2h,3h,3ah,4h,5h,6h,9h-phenaleno[1,2-d][1,3]dioxole

(1r,3ar,4s,6r)-1,4,7-trimethyl-6-(2-methylprop-1-en-1-yl)-1h,2h,3h,3ah,4h,5h,6h,9h-phenaleno[1,2-d][1,3]dioxole

C21H28O2 (312.2089188)


   

(2s,4'ar,8'ar)-2',5',5',8'a-tetramethyl-4'a,6',7',8'-tetrahydro-3h,4'h-spiro[1-benzofuran-2,1'-naphthalen]-5-ol

(2s,4'ar,8'ar)-2',5',5',8'a-tetramethyl-4'a,6',7',8'-tetrahydro-3h,4'h-spiro[1-benzofuran-2,1'-naphthalen]-5-ol

C21H28O2 (312.2089188)


   

10-hydroxy-1,6,6,9a-tetramethyl-1h,2h,7h,8h,9h-phenanthro[1,2-b]furan-11-one

10-hydroxy-1,6,6,9a-tetramethyl-1h,2h,7h,8h,9h-phenanthro[1,2-b]furan-11-one

C20H24O3 (312.1725354)


   

(8r,13r,16r)-13-hydroxy-8,16-dimethyl-1,9-dioxacyclohexadec-11-ene-2,5,10-trione

(8r,13r,16r)-13-hydroxy-8,16-dimethyl-1,9-dioxacyclohexadec-11-ene-2,5,10-trione

C16H24O6 (312.1572804)


   

4-[(r)-[(2s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl](hydroxy)methyl]quinolin-6-ol

4-[(r)-[(2s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl](hydroxy)methyl]quinolin-6-ol

C19H24N2O2 (312.18376839999996)


   

methyl (2z)-3-(4-{[(2e,5e)-3,7-dimethylocta-2,5,7-trien-1-yl]oxy}phenyl)prop-2-enoate

methyl (2z)-3-(4-{[(2e,5e)-3,7-dimethylocta-2,5,7-trien-1-yl]oxy}phenyl)prop-2-enoate

C20H24O3 (312.1725354)


   

13-hydroxy-3-isopropyl-1,8,13-trimethyltricyclo[7.4.1.0⁵,¹⁴]tetradeca-3,5,7,9(14)-tetraene-2,10-dione

13-hydroxy-3-isopropyl-1,8,13-trimethyltricyclo[7.4.1.0⁵,¹⁴]tetradeca-3,5,7,9(14)-tetraene-2,10-dione

C20H24O3 (312.1725354)


   

15-ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.0⁴,¹².0⁵,¹⁰.0¹⁶,¹⁸]icosa-4(12),5,7,9-tetraen-2-ol

15-ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.0⁴,¹².0⁵,¹⁰.0¹⁶,¹⁸]icosa-4(12),5,7,9-tetraen-2-ol

C19H24N2O2 (312.18376839999996)


   

6-[(4-methoxyphenyl)methyl]-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-6-ium

6-[(4-methoxyphenyl)methyl]-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-6-ium

[C19H22NO3]+ (312.1599602)


   

(9s)-3,4-dihydroxy-16-methoxy-10,10-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,13,15-hexaen-10-ium

(9s)-3,4-dihydroxy-16-methoxy-10,10-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,13,15-hexaen-10-ium

[C19H22NO3]+ (312.1599602)